https://curecurrent.com/trials/rtms-for-refractory-auditory-hallucinations-based-on-personalized-targets-using-magnetoencephalography-122007https://curecurrent.com/trials/relationship-between-physical-fitness-and-psychopathology-cognition-and-quality-of-life-in-patients-diagnosed-with-schiz-122008https://curecurrent.com/trials/schizophrenia-cognition-scale-development-122009https://curecurrent.com/trials/the-effect-of-salutogenic-based-interviewing-on-subjective-recovery-and-quality-of-life-in-schizophrenia-122010https://curecurrent.com/trials/effects-of-aerobic-exercise-cognitive-remediation-and-combined-intervention-in-schizophrenia-122011https://curecurrent.com/trials/cognitive-training-for-emotion-regulation-in-psychotic-disorders-122012https://curecurrent.com/trials/implementation-of-a-tool-for-reduction-of-cardiovascular-risk-in-patients-with-severe-mental-disorders-healthyheart-122013https://curecurrent.com/trials/a-register-study-of-effects-following-local-variation-in-rates-of-involuntary-care-122014https://curecurrent.com/trials/study-on-the-efficacy-and-safety-of-qlm1016-in-schizophrenia-122015https://curecurrent.com/trials/plan-d-vitamin-d-supplementation-in-psychotic-disorders-122016https://curecurrent.com/trials/the-effect-of-acceptance-and-commitment-therapy-intervention-on-caregiver-burden-in-caregivers-of-schizophrenia-patients-122017https://curecurrent.com/trials/treating-schizophrenia-by-correcting-abnormal-brain-development-122018https://curecurrent.com/trials/the-fragility-of-metaphors-frame-learning-loosing-and-how-to-train-them-122019https://curecurrent.com/trials/apathy-in-schizophrenia-122020https://curecurrent.com/trials/improving-real-world-function-for-persons-with-schizophrenia-a-single-case-experimental-design-122021https://curecurrent.com/trials/minnesota-community-based-cognitive-training-in-early-psychosis-122022https://curecurrent.com/trials/building-employment-skills-through-therapy-for-veterans-122023https://curecurrent.com/trials/investigation-of-objective-cognitive-effort-in-neuropsychological-evaluation-of-psychotic-disorders-122024https://curecurrent.com/trials/acp-104-in-acutely-psychotic-subjects-with-schizophrenia-122025https://curecurrent.com/trials/weight-management-program-for-patients-with-first-episode-psychosis-122026https://curecurrent.com/trials/an-exploratory-double-arm-8-week-study-to-explore-the-feasibility-and-acceptability-of-abbreviated-treatment-with-ct-156-122027https://curecurrent.com/trials/a-shared-decision-making-training-for-inpatients-with-schizophrenia-122028https://curecurrent.com/trials/nor-clozapine-kinetics-and-side-effects-in-therapy-resistant-schizophrenia-and-the-optimal-sampling-time-for-therapeutic-122029https://curecurrent.com/trials/a-four-week-clinical-trial-investigating-efficacy-and-safety-of-cannabidiol-as-a-treatment-for-acutely-ill-schizophrenic-122030https://curecurrent.com/trials/the-impact-of-aripiprazole-long-acting-on-myelin-and-cognition-in-the-onset-of-schizophrenia-122031https://curecurrent.com/trials/a-clinical-study-to-investigate-the-effect-of-an-investigational-drug-as-an-added-medication-to-an-antipsychotic-in-adul-122032https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-switching-from-oral-risperidone-to-risperidone-implant-122033https://curecurrent.com/trials/targeted-intervention-study-of-dtms-on-impaired-insight-in-early-psychosis-122034https://curecurrent.com/trials/safety-and-efficacy-of-brilaroxazine-rp5063-in-schizophrenia-122035https://curecurrent.com/trials/motivation-skills-training-for-schizophrenia-122036https://curecurrent.com/trials/neuromodulation-for-schizophrenia-122037https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-long-term-safety-and-tolerability-of-an-investigational-drug-in-people-with-schizophren-122038https://curecurrent.com/trials/imaging-synapses-with-11c-ucb-j-in-the-human-brain-122039https://curecurrent.com/trials/personalized-dual-target-rtms-for-patients-with-refractory-schizophrenia-122040https://curecurrent.com/trials/culturally-adapted-psychosocial-interventions-for-early-psychosis-in-a-low-resource-setting-122041https://curecurrent.com/trials/developing-dual-channel-transcranial-alternating-current-stimulations-targeting-negative-symptoms-in-schizophrenia-122042https://curecurrent.com/trials/a-probiotic-strategy-for-antipsychotic-induced-metabolic-dysfunction-122043https://curecurrent.com/trials/randomized-double-blind-placebo-control-study-in-patients-with-schizophrenia-122044https://curecurrent.com/trials/neural-correlates-of-social-touch-and-interoceptive-perception-as-potential-biomarker-for-impaired-social-functioning-122045https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-karxt-in-acutely-psychotic-hospitalized-adult-patients-with-schizophrenia-emerg-122046https://curecurrent.com/trials/study-of-intra-and-interpersonal-multimodal-synchronizations-in-a-social-interaction-in-individuals-with-a-diagnosis-of-122047https://curecurrent.com/trials/the-sub-sero-study-122048https://curecurrent.com/trials/effect-of-simulation-on-emotional-expression-and-perceived-family-burden-of-caregivers-122049https://curecurrent.com/trials/add-on-memantine-to-dopamine-modulation-to-improve-negative-symptoms-at-first-psychosis-122050https://curecurrent.com/trials/context-aware-mobile-intervention-for-social-recovery-in-serious-mental-illness-122051https://curecurrent.com/trials/virtual-reality-for-visual-perception-on-schizophrenia-122052https://curecurrent.com/trials/kf2022-3-trial-effect-of-tea-and-cola-beverage-on-absorption-of-risperidone-oral-solution-122053https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-kyn-5356-in-healthy-subjects-aged-18-to-55-years-122054https://curecurrent.com/trials/e-detection-tool-for-emerging-mental-disorders-122055https://curecurrent.com/trials/evoked-responses-as-pharmacodynamic-biomarkers-in-healthy-and-schizophrenic-participants-mk-4334-007-122056https://curecurrent.com/trials/psychosis-screening-in-juvenile-justice-122057https://curecurrent.com/trials/effects-of-online-metacognitive-training-group-on-distressing-beliefs-122058https://curecurrent.com/trials/challenge-a-randomised-clinical-trial-examining-virtual-reality-therapy-122059https://curecurrent.com/trials/establishing-a-clinical-database-and-biobank-for-schizophrenia-a-cohort-study-122060https://curecurrent.com/trials/evaluating-pharmacogenomics-based-pharmacotherapy-in-real-world-settings-for-schizophrenia-122061https://curecurrent.com/trials/avatar-mediated-therapy-versus-cognitive-behavioural-therapy-for-persisting-experiences-of-hearing-voices-122062https://curecurrent.com/trials/effects-of-music-beat-on-motor-function-in-individuals-at-risk-for-psychotic-onset-and-schizophrenia-patients-122063https://curecurrent.com/trials/rituximab-treatment-for-psychosis-and-or-obsessive-compulsive-disorder-with-probable-immune-system-involvement-122064https://curecurrent.com/trials/effects-of-lurasidone-on-left-ventricle-systolic-functions-122065https://curecurrent.com/trials/brain-circuitry-therapeutics-for-schizophrenia-122066https://curecurrent.com/trials/effects-of-tes-combined-with-retrieval-practice-on-semantic-memory-in-patients-with-schizophrenia-122067https://curecurrent.com/trials/multiomic-diagnostics-in-youth-with-psychosis-122068https://curecurrent.com/trials/service-user-and-staff-views-on-digital-remote-monitoring-for-psychosis-122069https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-asp4345-as-add-on-treatment-for-cognitive-impairment-in-subjects-with-schiz-122070https://curecurrent.com/trials/m1-schizophrenia-pet-study-122071https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-valbenazine-as-an-adjunctive-treatment-for-schizophrenia-122072https://curecurrent.com/trials/mobile-cbt-for-negative-symptoms-122073https://curecurrent.com/trials/the-atp-project-antipsychotic-tep-psychosis-122074https://curecurrent.com/trials/mobile-assisted-cognitive-behavior-therapy-for-negative-symptoms-in-schizophrenia-122075https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-asp6981-in-subjects-with-schizophreni-122076https://curecurrent.com/trials/a-study-to-assess-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-asp4345-in-patients-with-schizophrenia-122077https://curecurrent.com/trials/an-extension-study-to-assess-long-term-safety-tolerability-and-efficacy-of-karxt-in-adult-patients-with-schizophrenia-em-122078https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-and-safety-of-paliperidone-palmitate-in-subjects-with-acute-schizophrenia-122079https://curecurrent.com/trials/a-safety-tolerability-and-treatment-response-study-of-paliperidone-palmitate-administered-to-patients-with-schizophrenia-122080https://curecurrent.com/trials/a-study-on-the-preference-of-risperidone-dosage-forms-122081https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-pk-and-safety-tolerability-of-long-acting-oral-lyn-005-122082https://curecurrent.com/trials/nursing-intervention-in-weight-and-metabolic-syndrome-management-in-first-episode-psychosis-metakop-122083https://curecurrent.com/trials/nst-spark-preliminary-study-of-an-augmented-reality-ar-app-delivering-recovery-oriented-cognitive-therapy-for-negative-s-122084https://curecurrent.com/trials/a-study-of-olanzapine-samidorphan-tablets-in-adults-with-schizophrenia-122085https://curecurrent.com/trials/efficacy-of-an-early-antipsychotic-switch-in-case-of-poor-initial-response-to-the-treatment-of-schizophrenia-122086https://curecurrent.com/trials/adapted-physical-activity-program-for-patients-undergoing-antipsychotic-treatment-of-a-first-episode-of-psychosis-122087https://curecurrent.com/trials/hdac-inhibitor-augmentation-to-clozapine-122088https://curecurrent.com/trials/self-administered-cognitive-personalized-training-in-early-psychosis-122089https://curecurrent.com/trials/cognitive-behavioural-therapy-informed-groups-for-psychosis-122090https://curecurrent.com/trials/adjunctive-withania-somnifera-ashwagandha-for-persistent-symptoms-in-people-with-schizophrenia-122091https://curecurrent.com/trials/outcomes-of-antipsychotic-medication-used-in-the-emergency-department-122092https://curecurrent.com/trials/cvn058-effect-on-mismatch-negativity-in-schizophrenics-122093https://curecurrent.com/trials/autonomic-nervous-system-and-meridian-energy-in-patients-with-schizophrenia-122094https://curecurrent.com/trials/neural-biomarkers-of-electroconvulsive-therapy-response-122095https://curecurrent.com/trials/investigating-the-cognitive-source-of-visual-working-memory-impairment-in-schizophrenia-122096https://curecurrent.com/trials/patients-suffering-from-emotional-dysregulation-122097https://curecurrent.com/trials/cigarette-smoking-in-smokers-with-and-without-schizophrenia-122098https://curecurrent.com/trials/study-to-evaluate-the-long-term-safety-tolerability-and-durability-of-treatment-effect-of-alks-3831-122099https://curecurrent.com/trials/youth-experiences-and-health-study-122100https://curecurrent.com/trials/accelerated-rtms-for-psychomotor-slowing-122101https://curecurrent.com/trials/clozapine-hematological-monitoring-regulatory-compliance-assessment-in-psychiatry-122102https://curecurrent.com/trials/aspirin-in-young-psychotic-patients-122103https://curecurrent.com/trials/even-effects-of-vr-on-empathy-for-nature-in-patients-with-psychosis-and-depressive-disorders-122104https://curecurrent.com/trials/treatment-of-negative-symptoms-of-schizophrenia-by-rtms-122105https://curecurrent.com/trials/artificial-intelligence-to-measure-adherence-to-oral-medication-122106https://curecurrent.com/trials/neuroplasticity-in-tbi-and-schizophrenia-122107https://curecurrent.com/trials/maximizing-the-impact-of-neuroplasticity-using-transcranial-electrical-stimulation-study-2-122108https://curecurrent.com/trials/early-phase-schizophrenia-practice-based-research-to-improve-outcomes-122109https://curecurrent.com/trials/cannabinoids-and-cerebellar-motor-functioning-122110https://curecurrent.com/trials/a-double-blind-randomized-comparative-study-of-carliprazine-and-aripiprazole-in-patients-with-acute-schizophrenia-122111https://curecurrent.com/trials/evaluating-the-effects-of-adjunctive-aripiprazole-on-weight-and-metabolic-outcomes-in-females-122112https://curecurrent.com/trials/effect-and-cost-effectiveness-of-the-everyday-life-rehabilitation-intervention-122113https://curecurrent.com/trials/the-personalized-psychological-treatment-for-psychosis-122114https://curecurrent.com/trials/interest-of-emdr-schizophrenic-disorders-122115https://curecurrent.com/trials/evaluation-of-the-efficacy-of-transcranial-magnetic-stimulation-on-resistant-auditory-hallucinations-in-schizophrenia-122116https://curecurrent.com/trials/aripiprazole-for-bipolar-disorder-and-alcohol-use-disorder-122117https://curecurrent.com/trials/effect-of-virtual-reality-based-therapy-on-negative-symptoms-in-people-with-schizophrenia-122118https://curecurrent.com/trials/effect-of-exercise-on-clinical-symptoms-cognitive-performance-and-quality-of-life-in-schizophrenia-patients-treated-with-122119https://curecurrent.com/trials/social-skills-and-emotion-regulation-training-ssert-for-trauma-in-psychosis-122120https://curecurrent.com/trials/relate-efficacy-and-feasibility-of-a-cognitive-behavioural-module-for-distressing-auditory-verbal-hallucinations-122121https://curecurrent.com/trials/piloting-of-an-intervention-to-reduce-problematic-alcohol-use-in-early-phase-psychosis-patients-122122https://curecurrent.com/trials/retinal-and-visual-cortical-response-in-early-psychosis-122123https://curecurrent.com/trials/effectiveness-of-the-combination-of-water-aerobics-and-metacognitive-training-122124https://curecurrent.com/trials/exploring-the-effectiveness-of-digital-anti-stigma-therapy-on-illness-perception-and-perceived-stigma-in-patients-with-s-122125https://curecurrent.com/trials/a-study-on-the-brain-mechanism-of-ctbs-in-improving-medication-resistant-auditory-hallucinations-in-schizophrenia-122126https://curecurrent.com/trials/switching-antipsychotics-abrupt-discontinuation-versus-overlap-122127https://curecurrent.com/trials/vlt-015-in-patients-with-schizophrenia-122128https://curecurrent.com/trials/temporal-memory-in-schizophrenic-patients-122129https://curecurrent.com/trials/itbs-on-negative-symptoms-and-cognitive-function-in-schizophrenia-122130https://curecurrent.com/trials/study-by-electroencephalography-of-the-link-between-the-lack-of-self-compassion-and-the-disorder-of-empathy-in-schizophr-122131https://curecurrent.com/trials/translational-neuroscience-optimization-of-glyt1-inhibitor-122132https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-with-placebo-and-olanzapine-41022-p05947-122133https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-with-placebo-and-haloperidol-41023-p05926-completed-122134https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-using-an-active-control-in-subjects-with-schizophrenia-or-schizoaffective-disorder-2551-122135https://curecurrent.com/trials/ziprasidone-in-early-onset-schizophrenia-spectrum-disorders-122136https://curecurrent.com/trials/an-acceptability-study-of-unflavored-asenapine-versus-raspberry-flavored-asenapine-in-stable-patients-with-a-psychotic-d-122137https://curecurrent.com/trials/cognitive-behavioral-therapy-cbt-study-evaluating-the-updating-of-persecutory-beliefs-122138https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-compared-with-olanzapine-in-patients-with-persistent-negative-symptoms-of-schizophrenia-122139https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-with-placebo-and-olanzapine-41021-p05933-122140https://curecurrent.com/trials/horyzons-implementation-in-clinical-practice-122141https://curecurrent.com/trials/improving-neurocognitive-deficits-and-function-in-schizophrenia-with-transcranial-magnetic-stimulation-122142https://curecurrent.com/trials/study-to-assess-the-safety-and-pharmacokinetics-of-cy6463-in-participants-with-stable-schizophrenia-122143https://curecurrent.com/trials/childhood-maltreatment-traumatic-experiences-and-stress-associated-parameters-in-schizophrenia-spectrum-disorders-122144https://curecurrent.com/trials/psychoneuromentalism-disorder-a-medical-condition-that-affects-people-with-psychological-impairments-from-health-issues-122145https://curecurrent.com/trials/a-study-to-assess-the-effects-of-ro6889450-ralmitaront-in-participants-with-schizophrenia-or-schizoaffective-disorder-an-122146https://curecurrent.com/trials/a-pilot-trial-of-tapering-antipsychotics-for-patients-in-remitted-psychosis-co-administering-with-n-acetylcysteine-122147https://curecurrent.com/trials/cognitive-adaption-training-effectiveness-in-real-world-settings-and-mechanism-of-action-cat-em-122148https://curecurrent.com/trials/application-of-group-interpersonal-psychotherapy-ipt-g-to-family-members-caring-for-patients-with-schizophrenia-122149https://curecurrent.com/trials/a-clinical-pharmacology-trial-of-brexpiprazole-once-weekly-qw-formulation-administered-as-single-and-multiple-oral-doses-122150https://curecurrent.com/trials/effects-of-tdcs-combined-with-retrieval-practice-on-semantic-memory-in-patients-with-schizophrenia-122151https://curecurrent.com/trials/lurasidone-non-interventional-study-in-schizophrenia-patients-122152https://curecurrent.com/trials/models-of-auditory-hallucination-122153https://curecurrent.com/trials/functional-magnetic-resonance-imaging-study-in-schizophrenia-patients-and-correlation-with-cognitive-impairments-122154https://curecurrent.com/trials/tryptophan-mri-in-people-with-schizophrenia-and-healthy-controls-122155https://curecurrent.com/trials/tdcs-and-executive-function-training-for-schizophrenia-122156https://curecurrent.com/trials/combining-mhealth-and-nurse-delivered-care-to-improve-the-outcomes-of-people-with-serious-mental-illness-in-west-africa-122157https://curecurrent.com/trials/feasibility-trial-of-a-lifestyle-intervention-for-chr-p-122158https://curecurrent.com/trials/psychosis-associated-with-methylphenidate-in-children-and-adolescents-122159https://curecurrent.com/trials/vr-based-avatar-therapy-for-treatment-of-auditory-hallucinations-122160https://curecurrent.com/trials/effect-of-atenolol-versus-ivabradine-on-hrv-in-trs-patients-on-clozapine-with-tachycardia-a-randomised-control-trial-122161https://curecurrent.com/trials/kombucha-tea-for-improving-defecation-in-patients-with-schizophrenia-a-randomized-controlled-study-122162https://curecurrent.com/trials/motivational-interviewing-for-patients-with-acute-psychosis-122163https://curecurrent.com/trials/maintenance-electroconvulsive-therapy-ect-versus-aripiprazole-in-clozapine-resistant-schizophrenia-122164https://curecurrent.com/trials/obstructive-sleep-apnea-treatment-in-serious-mental-illness-122165https://curecurrent.com/trials/efficacy-and-safety-of-tacs-vs-tdcs-in-schizophrenia-122166https://curecurrent.com/trials/cognitive-biases-under-ketamine-122167https://curecurrent.com/trials/qualitative-study-of-emotional-regulation-in-schizophrenia-122168https://curecurrent.com/trials/music-therapy-advocacy-recording-intervention-mtar-on-internalized-stigma-122169https://curecurrent.com/trials/an-extension-study-of-safety-and-tolerability-of-sep-363856-in-adult-subjects-with-schizophrenia-122170https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-sep-363856-in-acutely-psychotic-adults-with-schizophrenia-122171https://curecurrent.com/trials/cognitive-remediation-in-schizophrenia-efficacy-and-role-of-neuroplasticity-in-top-down-and-bottom-up-mechanisms-122172https://curecurrent.com/trials/lumateperone-for-the-improvement-of-apathy-in-patients-with-psychotic-symptoms-122173https://curecurrent.com/trials/critical-time-intervention-peer-support-122174https://curecurrent.com/trials/fitforlife-exercise-in-care-of-psychosis-122175https://curecurrent.com/trials/a-clinical-study-that-will-assess-the-effect-of-sep-363856-or-prior-antipsychotic-pa-standard-of-care-on-body-weight-ass-122176https://curecurrent.com/trials/study-assessing-sep-363856-in-male-and-female-volunteers-with-high-or-low-schizotype-characteristics-122177https://curecurrent.com/trials/a-clinical-study-to-investigate-the-effect-of-an-investigational-drug-on-electrocardiogram-intervals-in-adults-with-schi-122178https://curecurrent.com/trials/a-clinical-study-to-learn-if-sep-363856-has-physical-dependence-in-adults-with-schizophrenia-122179https://curecurrent.com/trials/study-assessing-the-safety-tolerability-and-pharmacokinetics-of-sep-363856-in-male-and-female-subjects-with-schizophreni-122180https://curecurrent.com/trials/a-clinical-study-that-will-assess-how-food-moves-through-the-stomach-and-effects-blood-glucose-levels-in-subjects-with-s-122181https://curecurrent.com/trials/a-study-assessing-the-safety-tolerability-and-pharmacokinetics-of-sep-363856-in-male-and-female-subjects-with-schizophre-122182https://curecurrent.com/trials/a-clinical-study-that-will-assess-the-effect-of-sep-363856-and-prior-antipsychotic-pa-standard-of-care-on-glucose-and-re-122183https://curecurrent.com/trials/a-clinical-trial-study-to-determine-the-effect-of-an-investigational-drug-sep-363856-has-on-the-way-that-the-drug-metfor-122184https://curecurrent.com/trials/an-open-label-single-arm-clinical-trial-evaluating-the-safety-and-efficacy-of-amisulpride-in-treating-patients-with-schi-122185https://curecurrent.com/trials/extreme-challenges-psychopathology-treatment-experiences-among-severly-selfharming-inpatients-in-norway-122186https://curecurrent.com/trials/the-effects-of-simultaneous-training-of-walking-and-cognitive-tasks-on-cognitive-functions-of-people-with-schizophrenia-122187https://curecurrent.com/trials/cognitive-and-balance-dual-task-training-for-people-with-schizophrenia-122188https://curecurrent.com/trials/acceptance-and-commitment-therapy-based-lifestyle-counselling-programme-for-early-psychosis-on-physical-activity-122189https://curecurrent.com/trials/6-week-trial-of-the-efficacy-and-safety-of-asenapine-compared-to-placebo-in-participants-with-an-acute-exacerbation-of-s-122190https://curecurrent.com/trials/the-hi-tacs-on-cognitive-function-in-patients-with-schizophrenia-a-pilot-study-122191https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-asenapine-in-participants-with-an-acute-exacerbation-of-schizophrenia-p05688-122192https://curecurrent.com/trials/impact-of-cognitive-metacognitive-performance-on-knowledge-learning-when-conducting-therapeutic-education-programs-122193https://curecurrent.com/trials/the-effects-of-tdcs-on-the-neuronal-mechanisms-of-cognitive-control-in-schizophrenia-122194https://curecurrent.com/trials/an-open-label-study-to-assess-the-long-term-safety-tolerability-effectiveness-and-durability-of-effect-of-karxt-in-patie-122195https://curecurrent.com/trials/investigation-of-the-effects-of-family-focused-therapy-in-the-early-period-of-bipolar-disorder-and-psychotic-disorder-122196https://curecurrent.com/trials/acceptance-and-commitment-therapy-act-in-early-psychosis-patients-122197https://curecurrent.com/trials/a-neurofeedback-intervention-to-improve-working-memory-in-schizophrenia-122198https://curecurrent.com/trials/the-danish-region-midt-schizophrenia-cohort-122199https://curecurrent.com/trials/long-term-extension-trial-of-asenapine-in-subjects-with-schizophrenia-study-p06125-122200https://curecurrent.com/trials/long-term-study-of-asenapine-in-participants-with-residual-subtype-receiving-multiple-or-and-high-dose-drugs-or-treatmen-122201https://curecurrent.com/trials/study-to-evaluate-safety-efficacy-of-naben-as-add-on-treatment-for-schizophrenia-in-adults-122202https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-sublingual-asenapine-in-a-pediatric-population-with-122203https://curecurrent.com/trials/benefits-of-combining-mct-with-cr-in-the-recovery-of-patients-with-psychotic-spectrum-disorders-122204https://curecurrent.com/trials/flexible-dose-long-term-safety-study-of-asenapine-for-the-treatment-of-schizophrenia-in-adolescents-p05897-122205https://curecurrent.com/trials/fixed-dose-efficacy-and-safety-study-of-asenapine-for-the-treatment-of-schizophrenia-in-adolescents-p05896-122206https://curecurrent.com/trials/individual-placement-and-support-and-or-cognitive-remediation-therapy-added-to-tau-in-patients-with-early-schizophrenia-122207https://curecurrent.com/trials/brain-stimulation-clinical-symptoms-and-cognition-122208https://curecurrent.com/trials/cognitive-behavior-therapy-cbt-informed-mobile-application-for-first-episode-psychosis-122209https://curecurrent.com/trials/learning-through-play-plus-for-psychosis-122210https://curecurrent.com/trials/a-cannabis-harm-reduction-e-intervention-for-young-cannabis-users-with-early-psychosis-122211https://curecurrent.com/trials/the-efficacy-of-metacognitive-skills-training-in-the-context-of-forensic-psychiatric-care-122212https://curecurrent.com/trials/physical-activity-level-in-psychosis-patients-122213https://curecurrent.com/trials/brain-stimulation-and-cognitive-training-efficacy-122214https://curecurrent.com/trials/adaptive-phase-ii-study-to-evaluate-the-safety-efficacy-of-naben-122215https://curecurrent.com/trials/efficacy-of-prebiotic-and-probiotic-dietary-modulation-in-schizophrenic-disorders-122216https://curecurrent.com/trials/cigarette-consumption-after-switching-to-high-or-low-nicotine-strenght-e-cigarettes-in-smokers-with-schizophrenia-122217https://curecurrent.com/trials/goals-in-focus-cbt-for-motivational-negative-symptoms-of-psychosis-122218https://curecurrent.com/trials/biomarkers-of-conversion-risk-and-treatment-response-in-early-stage-schizophrenia-122219https://curecurrent.com/trials/honest-open-proud-for-psychotic-and-bipolar-disorder-in-norway-122220https://curecurrent.com/trials/impact-of-inflammation-on-reward-circuits-motivational-deficits-and-negative-symptoms-in-schizophrenia-122221https://curecurrent.com/trials/comparative-effectiveness-of-adaptive-treatment-strategies-for-schizophrenia-122222https://curecurrent.com/trials/hippocampal-memory-circuits-in-delusions-122223https://curecurrent.com/trials/evaluation-of-tolcapone-as-a-cognitive-enhancer-in-schizophrenia-122224https://curecurrent.com/trials/neural-oscillations-as-genetic-and-functional-biomarkers-in-normal-and-disease-states-122225https://curecurrent.com/trials/safety-and-tolerability-of-bi-409306-in-patients-with-schizophrenia-122226https://curecurrent.com/trials/effect-of-tdcs-on-inflammatory-biomarkers-in-chronic-schizophrenia-122227https://curecurrent.com/trials/individualized-repetitive-transcranial-magnetic-stimulation-for-auditory-verbal-hallucinations-122228https://curecurrent.com/trials/familial-and-functional-study-of-genetic-variants-identified-in-people-with-schizophrenia-bipolar-disorder-autism-spectr-122229https://curecurrent.com/trials/the-effect-of-developing-psychological-resilience-on-functionality-in-schizophrenia-patients-122230https://curecurrent.com/trials/evaluation-of-the-individual-early-psychoeducation-program-for-schizophrenic-disorders-in-inpatients-122231https://curecurrent.com/trials/raloxifene-as-an-adjuvant-treatment-of-the-negative-symptoms-of-schizophrenia-in-post-menopausal-women-122232https://curecurrent.com/trials/the-safety-and-efficacy-of-lurasidone-in-subjects-with-schizophrenia-switched-from-olanzapine-122233https://curecurrent.com/trials/effects-on-social-and-cognition-functions-of-blonanserin-in-first-episode-schizophrenia-patients-122234https://curecurrent.com/trials/the-safety-and-effectiveness-of-latuda-post-marketing-surveillance-in-the-treatment-of-chinese-schizophrenia-patients-122235https://curecurrent.com/trials/the-safety-and-efficacy-of-lurasidone-with-different-initiation-dose-in-chinese-acute-phase-patients-with-schizophrenia-122236https://curecurrent.com/trials/rtms-for-auditory-hallucinations-guided-by-magnetoencephalography-122237https://curecurrent.com/trials/facilitating-engagement-in-evidence-based-treatment-for-early-psychosis-122238https://curecurrent.com/trials/the-impact-of-acceptance-and-commitment-therapy-on-stigmatization-122239https://curecurrent.com/trials/focus-groups-on-cognitive-function-in-psychosis-122240https://curecurrent.com/trials/contrasting-group-therapy-methods-for-psychosis-122241https://curecurrent.com/trials/comparison-of-a-speech-language-assessment-tool-for-pragmatic-and-discourse-skills-in-schizophrenia-spectrum-disorders-122242https://curecurrent.com/trials/a-clinical-trial-to-evaluate-safety-tolerance-and-pharmacokinetics-of-jx11502ma-capsule-in-patients-with-schizophrenia-122243https://curecurrent.com/trials/an-open-label-single-arm-study-of-the-efficacy-of-accelerated-intermittent-theta-burst-stimulation-in-schizophrenia-pati-122244https://curecurrent.com/trials/emotiph-e-mental-health-solution-for-patients-with-schizophrenia-122245https://curecurrent.com/trials/the-effect-of-psychoeducation-focused-on-reducing-internalized-stigma-122246https://curecurrent.com/trials/exploring-hand-function-in-people-with-schizophrenia-based-on-perspective-of-sensorimotor-control-122247https://curecurrent.com/trials/exercise-and-markers-of-medial-temporal-health-in-youth-at-risk-for-psychosis-122248https://curecurrent.com/trials/feasibility-of-an-early-detection-program-for-early-psychosis-on-a-college-campus-122249https://curecurrent.com/trials/antidepressant-controlled-trial-for-negative-symptoms-in-schizophrenia-122250https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-to-improve-gesture-control-122251https://curecurrent.com/trials/treatment-of-auditory-hallucinations-in-schizophrenia-with-bilateral-theta-burst-stimulation-122252https://curecurrent.com/trials/clinical-efficacy-and-adverse-reactions-of-antipsychotic-treatment-122253https://curecurrent.com/trials/psyche-cognitive-remediation-social-recovery-study-122254https://curecurrent.com/trials/combining-clemastine-and-aerobic-exercise-to-treat-cognitive-dysfunction-in-schizophrenia-by-targeting-myelin-plasticity-122255https://curecurrent.com/trials/study-to-compare-clozapine-vs-treatment-as-usual-in-people-with-intellectual-disability-treatment-resistant-psychosis-122256https://curecurrent.com/trials/testing-the-effectiveness-of-the-welcome-basket-intervention-122257https://curecurrent.com/trials/mobile-after-care-support-app-pilot-rct-122258https://curecurrent.com/trials/developing-clinical-tools-to-communicate-genetic-risk-for-individuals-who-are-clinical-high-risk-for-psychosis-122259https://curecurrent.com/trials/study-to-evaluate-the-pk-profiles-of-ly03010-in-patients-with-schizophrenia-or-schizoaffective-disorder-122260https://curecurrent.com/trials/vr-based-therapy-to-treat-anxiety-in-dual-diagnosis-122261https://curecurrent.com/trials/music-therapy-to-reduce-anxiety-in-community-dwelling-individuals-with-severe-mental-illness-122262https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-efficacy-and-safety-of-sep-363856-in-acutely-psychotic-people-with-schizophrenia-follow-122263https://curecurrent.com/trials/pragmatic-assessment-and-treatment-for-the-health-system-122264https://curecurrent.com/trials/hippotherapy-in-patients-with-schizophrenia-122265https://curecurrent.com/trials/inflammatory-response-in-schizophrenia-122266https://curecurrent.com/trials/ketogenic-diet-for-psychotic-disorders-122267https://curecurrent.com/trials/dance-movement-therapy-for-bone-mineral-density-in-schizophrenia-122268https://curecurrent.com/trials/the-phase-i-study-of-hs-10509-in-chinese-adult-subjects-122269https://curecurrent.com/trials/effects-of-adherence-therapy-on-medication-adherence-in-patients-with-schizophrenia-spectrum-disorder-122270https://curecurrent.com/trials/belief-updating-speech-and-psychosis-122271https://curecurrent.com/trials/mindfulness-based-family-psychoeducation-intervention-for-early-psychosis-122272https://curecurrent.com/trials/the-role-of-glutamatergic-function-in-the-pathophysiology-of-treatment-resistant-schizophrenia-122273https://curecurrent.com/trials/side-effects-of-psychiatric-medications-a-nested-case-control-cohort-historical-prospective-study-122274https://curecurrent.com/trials/a-study-to-evaluate-3-dose-levels-of-luvadaxistat-of-adults-with-negative-symptoms-of-schizophrenia-122275https://curecurrent.com/trials/neurofeedback-training-for-high-risk-psychosis-122276https://curecurrent.com/trials/imagery-interventions-for-auditory-vocal-hallucinations-122277https://curecurrent.com/trials/a-study-to-evaluate-multiple-oral-doses-of-luvadaxistat-in-adults-with-schizophrenia-122278https://curecurrent.com/trials/cognitive-effects-of-adjuvant-vortioxetine-in-early-schizophrenia-122279https://curecurrent.com/trials/validation-of-the-lithuanian-version-of-the-bnss-cdss-and-the-scors-122280https://curecurrent.com/trials/psychological-interventions-for-complex-ptsd-and-schizophrenia-spectrum-disorder-picasso-trial-122281https://curecurrent.com/trials/tdcs-stress-and-risk-for-schizophrenia-122282https://curecurrent.com/trials/striatal-connectivity-and-clinical-outcome-in-psychosis-122283https://curecurrent.com/trials/avatar-intervention-for-the-treatment-of-cannabis-use-disorder-in-patients-with-severe-mental-health-disorders-122284https://curecurrent.com/trials/an-extension-protocol-for-patients-who-previously-completed-the-tms-pilot-study-122285https://curecurrent.com/trials/impact-of-tdcs-on-cannabis-craving-in-schizophrenia-122286https://curecurrent.com/trials/structural-and-functional-correlates-of-clinical-response-to-rtms-treatment-in-schizophrenia-patients-with-resistant-aud-122287https://curecurrent.com/trials/cerebral-impact-of-cognitive-remediation-for-people-suffering-from-schizophrenia-122288https://curecurrent.com/trials/cannabis-and-thought-disorder-in-schizophrenia-122289https://curecurrent.com/trials/role-of-vitamin-d-supplementation-in-schizophrenia-122290https://curecurrent.com/trials/neuropsychological-assessment-of-remediation-for-cognitive-impairments-in-schizophrenia-122291https://curecurrent.com/trials/varenicline-treatment-in-alcohol-and-nicotine-dependent-patients-with-schizophrenia-122292https://curecurrent.com/trials/reactivity-of-the-vestibular-system-to-caloric-vestibular-stimulation-in-schizophrenia-122293https://curecurrent.com/trials/adjunctive-vortioxetine-in-schizophrenia-122294https://curecurrent.com/trials/antipsychotic-medication-extended-dosing-study-122295https://curecurrent.com/trials/rct-comparing-avatar-intervention-to-supportive-intervention-to-reduce-cannabis-use-in-patients-with-psychotic-disorders-122296https://curecurrent.com/trials/modified-psychodynamic-psychotherapy-for-patients-with-schizophrenia-122297https://curecurrent.com/trials/comparaison-of-avatar-therapy-to-cognitive-behavioral-therapy-in-schizophrenia-with-treatment-refractory-hallucinations-122298https://curecurrent.com/trials/metacognitive-training-for-negative-symptoms-122299https://curecurrent.com/trials/the-effect-of-multiple-occupational-therapies-on-functional-remission-and-subjective-recovery-for-schizophrenia-122300https://curecurrent.com/trials/pharmacological-modulation-of-hippocampal-activity-in-psychosis-2-122301https://curecurrent.com/trials/the-effect-of-social-skills-intervention-on-praxis-and-social-functioning-in-individuals-with-schizophrenia-122302https://curecurrent.com/trials/project-bridge-peer-health-navigator-intervention-122303https://curecurrent.com/trials/mindfulness-group-therapy-and-psychosis-training-decreases-anxiety-and-depression-122304https://curecurrent.com/trials/increasing-medication-check-participation-through-applying-ct-r-122305https://curecurrent.com/trials/physical-exercise-in-patients-with-schizophrenia-122306https://curecurrent.com/trials/childhood-trauma-in-schizophrenia-exploration-of-links-between-gene-expression-cerebral-morphology-and-symptomatology-122307https://curecurrent.com/trials/hd-tdcs-for-hallucinations-122308https://curecurrent.com/trials/delusion-ideation-in-the-context-of-everyday-life-122309https://curecurrent.com/trials/resourcefulness-group-intervention-on-recovery-and-quality-of-life-122310https://curecurrent.com/trials/effectiveness-of-a-mindfulness-based-group-training-addressing-social-cognition-in-first-episode-psychosis-ages-mind-122311https://curecurrent.com/trials/effect-of-nutritional-counseling-on-anthropometry-and-biomarkers-in-patients-diagnosed-with-schizophrenia-psychosis-or-b-122312https://curecurrent.com/trials/needs-tailored-nurse-led-recovery-program-for-community-dwelling-people-with-schizophrenia-122313https://curecurrent.com/trials/investigating-the-role-of-diazepam-on-brain-function-and-chemistry-in-psychosis-risk-122314https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-in-early-psychosis-and-the-functional-connectivity-biotypes-122315https://curecurrent.com/trials/stratifying-psychoses-for-personalized-repetitive-tms-in-persistent-negative-symptoms-alleviation-122316https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-ctp-692-as-an-adjunctive-treatment-in-adults-with-schizophrenia-122317https://curecurrent.com/trials/trial-to-evaluate-the-short-term-safety-efficacy-of-brexpiprazole-monotherapy-in-the-treatment-of-adolescents-with-schiz-122318https://curecurrent.com/trials/psychological-treatment-in-psychiatric-inpatient-care-122319https://curecurrent.com/trials/personalized-prospective-study-evaluation-of-the-efficacy-and-safety-of-noninvasive-neuromodulation-of-tms-in-subjects-w-122320https://curecurrent.com/trials/mindfulness-and-cognition-in-schizophrenia-122321https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-karxt-in-acutely-psychotic-hospitalized-adult-patients-with-schizophrenia-emerg-122322https://curecurrent.com/trials/effect-of-acceptance-and-commitment-therapy-on-psychotic-severity-122323https://curecurrent.com/trials/characterizing-response-to-antipsychotics-in-schizophrenia-122324https://curecurrent.com/trials/brain-biomarker-on-inflammation-response-122325https://curecurrent.com/trials/virtual-group-fitness-and-nutrition-intervention-for-individuals-with-psychosis-122326https://curecurrent.com/trials/psychotherapy-for-psychosis-adverse-events-and-substance-misuse-122327https://curecurrent.com/trials/aripiprazole-lauroxil-for-preventing-psychotic-relapse-after-an-initial-schizophrenia-episode-122328https://curecurrent.com/trials/from-brain-currents-to-interpersonal-flow-investigating-the-social-processing-stream-of-schizophrenia-122329https://curecurrent.com/trials/selective-estrogen-receptor-modulators-serms-a-potential-treatment-for-psychotic-symptoms-of-schizophrenia-in-men-122330https://curecurrent.com/trials/enhancing-cognitive-training-through-exercise-following-a-first-schizophrenia-episode-122331https://curecurrent.com/trials/insight-into-hippocampal-neuroplasticity-in-schizophrenia-by-investigating-molecular-pathways-during-physical-training-122332https://curecurrent.com/trials/this-study-tests-whether-bi-425809-together-with-brain-training-using-a-computer-improves-mental-functioning-in-patients-122333https://curecurrent.com/trials/a-study-based-on-the-french-national-health-insurance-database-in-participants-with-psychotic-disorders-122334https://curecurrent.com/trials/a-trial-of-multiple-doses-of-aripiprazole-in-adults-with-schizophrenia-or-bipolar-1-disorder-122335https://curecurrent.com/trials/inpatient-group-acceptance-and-commitment-therapy-act-for-psychosis-spectrum-disorder-122336https://curecurrent.com/trials/be-outspoken-and-overcome-stigmatizing-thoughts-boost-group-for-early-psychosis-122337https://curecurrent.com/trials/comparative-effectiveness-of-cet-vs-sst-in-smi-serious-mental-illness-122338https://curecurrent.com/trials/electrical-brain-stimulation-for-cognitive-impairment-in-schizophrenia-a-tdcs-fmri-study-122339https://curecurrent.com/trials/the-characteristics-of-treatment-resistant-schizophrenia-from-the-illness-onset-122340https://curecurrent.com/trials/exploring-the-effect-of-rumination-focused-cognitive-behaviour-therapy-in-patients-with-schizophrenia-122341https://curecurrent.com/trials/participatory-messaging-in-the-ucla-psychiatry-partial-hospitalization-and-intensive-outpatient-programs-122342https://curecurrent.com/trials/using-digital-media-advertising-to-reduce-the-duration-of-untreated-psychosis-122343https://curecurrent.com/trials/norwegian-adult-mental-health-registry-122344https://curecurrent.com/trials/efficacy-and-safety-study-of-aripiprazole-to-treat-schizophrenia-122345https://curecurrent.com/trials/the-effect-of-recognition-and-expression-of-emotions-program-applied-to-schizophrenia-patients-122346https://curecurrent.com/trials/effects-of-metformin-and-fish-oil-on-treatment-with-clozapine-122347https://curecurrent.com/trials/acetylcholine-tobacco-smoking-genes-and-nicotinic-receptors-122348https://curecurrent.com/trials/rufus-group-rumination-focused-cbt-for-negative-symptoms-122349https://curecurrent.com/trials/pharmacokinetic-safety-and-tolerability-study-of-risperidone-ism-at-different-dose-strengths-122350https://curecurrent.com/trials/evaluating-sublingual-dexmedetomidine-for-moderate-to-severe-agitation-in-inpatients-with-schizophrenia-or-bipolar-disor-122351https://curecurrent.com/trials/biological-implications-of-the-overlapping-phenomenon-between-childhood-schizophrenia-and-autism-spectrum-disorders-hete-122352https://curecurrent.com/trials/neuromodulation-of-social-cognitive-circuitry-in-people-with-schizophrenia-spectrum-disorders-122353https://curecurrent.com/trials/hct-effect-among-patients-with-psychotic-disorders-122354https://curecurrent.com/trials/a-trial-of-the-efficacy-and-the-safety-of-ro6889450-ralmitaront-vs-placebo-in-patients-with-an-acute-exacerbation-of-sch-122355https://curecurrent.com/trials/cognitive-behavioral-therapy-for-insomnia-cbt-i-in-schizophrenia-sleepins-122356https://curecurrent.com/trials/augmentation-of-working-memory-training-with-transcranial-direct-current-stimulation-in-patients-with-schizophrenia-122357https://curecurrent.com/trials/illness-management-and-recovery-a-cluster-randomized-controlled-trial-within-a-forensic-mental-inpatient-setting-122358https://curecurrent.com/trials/study-on-the-bioequivalence-of-amisulpride-orally-disintegrating-tablets-in-human-body-122359https://curecurrent.com/trials/the-phenotypic-and-genetic-profile-of-patients-with-early-onset-schizophrenia-associated-with-autism-spectrum-disorder-122360https://curecurrent.com/trials/health-outcomes-via-positive-engagement-in-schizophrenia-122361https://curecurrent.com/trials/virtual-reality-avatar-therapy-for-people-hearing-voices-122362https://curecurrent.com/trials/peer-support-for-exercise-in-older-veterans-with-psychotic-disorders-122363https://curecurrent.com/trials/partners-in-wellness-evaluation-of-a-pay-for-performance-program-for-high-utilizers-of-mental-health-services-122364https://curecurrent.com/trials/transcranial-weak-current-stimulation-treatments-for-working-memory-dysfunction-in-schizophrenia-122365https://curecurrent.com/trials/using-speech-to-monitor-symptom-severity-in-arabic-speaking-patients-with-schizophrenia-122366https://curecurrent.com/trials/effectiveness-of-trauma-therapy-using-prolonged-exposure-for-patients-with-ptsd-and-a-comorbid-psychotic-disorder-122367https://curecurrent.com/trials/endocannabinoid-activity-remodulation-for-psychosis-liability-in-youth-122368https://curecurrent.com/trials/exercise-intervention-for-people-with-schizophrenia-crew-122369https://curecurrent.com/trials/antipsychotic-induced-hyperprolactinemaia-as-risk-factor-for-periodontitis-in-schizophrenic-patients-122370https://curecurrent.com/trials/resiliency-training-on-the-college-campus-122371https://curecurrent.com/trials/community-reinforcement-approach-and-family-training-for-substance-use-in-early-psychosis-intervention-122372https://curecurrent.com/trials/tom-psychotherapy-and-brain-networks-in-eos-122373https://curecurrent.com/trials/low-and-high-frequency-repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-resistant-auditory-hallucin-122374https://curecurrent.com/trials/combining-rtms-with-varenicline-to-prevent-smoking-lapse-in-schizophrenia-122375https://curecurrent.com/trials/evaluation-of-excellence-in-italy-s-residence-for-execution-of-security-measure-122376https://curecurrent.com/trials/effects-of-repetitive-transcranial-magnetic-stimulation-rtms-on-cannabis-use-and-cognitive-outcomes-in-schizophrenia-122377https://curecurrent.com/trials/investigation-of-community-reablement-on-instrumental-activities-of-daily-living-in-people-with-schizophrenia-122378https://curecurrent.com/trials/the-im-zbulle-study-z-track-and-airlock-techniques-during-intramuscular-injection-of-haloperidol-decanoate-122379https://curecurrent.com/trials/future-mental-projections-in-schizophrenia-122380https://curecurrent.com/trials/topiramate-vs-metformin-on-cardio-metabolic-profile-in-schizophrenia-on-atypical-antipsychotics-122381https://curecurrent.com/trials/learning-and-executive-function-disorders-in-children-and-psychosis-risk-at-adult-age-122382https://curecurrent.com/trials/is-cognitive-training-an-option-122383https://curecurrent.com/trials/does-cannabidiol-attenuate-the-acute-effects-of-9-tetrahydrocannabinol-intoxication-in-individuals-diagnosed-with-schizo-122384https://curecurrent.com/trials/cbt-to-reduce-insomnia-and-improve-social-recovery-in-early-psychosis-122385https://curecurrent.com/trials/indoor-artificial-light-at-night-and-the-relapse-risk-of-schizophrenia-122386https://curecurrent.com/trials/ontrackny-with-the-option-of-social-network-meetings-122387https://curecurrent.com/trials/testing-the-interactive-effects-of-delta-9-tetrahydrocannabinol-and-pregnenolone-122388https://curecurrent.com/trials/interactions-of-fronto-parietal-high-frequency-rtms-on-anterior-cingulate-cortex-activation-in-schizophrenia-122389https://curecurrent.com/trials/bizarreness-and-anomalous-self-experiences-in-schizophrenia-122390https://curecurrent.com/trials/rtms-as-a-probe-of-episodic-memory-neurocircuitry-in-schizophrenia-122391https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-efficacy-study-of-hs-10380-in-patients-with-schizophrenia-122392https://curecurrent.com/trials/pet-trial-to-evaluate-target-occupancy-of-cvl-231-on-brain-receptors-following-oral-dosing-122393https://curecurrent.com/trials/berberine-effects-on-clinical-symptoms-and-metabolic-disturbance-in-patients-with-schizophrenia-122394https://curecurrent.com/trials/tocilizumab-in-schizophrenia-122395https://curecurrent.com/trials/siltuximab-in-schizophrenia-122396https://curecurrent.com/trials/v-sual-arts-group-therapy-based-on-watson-s-human-care-model-in-ind-v-duals-w-th-sch-zophren-a-122397https://curecurrent.com/trials/add-on-aripiprazole-on-cardiometabolic-profile-in-treatment-resistant-schizophrenia-rct-122398https://curecurrent.com/trials/effect-of-applying-cognitive-defusion-techniques-on-mindful-awareness-cognitive-fusion-and-believability-of-delusions-am-122399https://curecurrent.com/trials/experience-of-horticultural-group-therapy-among-people-with-chronic-schizophrenia-122400https://curecurrent.com/trials/assessment-of-schizophrenia-patients-clinical-study-experiences-122401https://curecurrent.com/trials/relapse-prevention-study-in-patients-with-schizophrenia-122402https://curecurrent.com/trials/evaluation-of-the-efficacy-of-immunomodulatory-therapy-in-case-of-psychiatric-disorders-with-proven-dysimmunity-122403https://curecurrent.com/trials/suicide-prevention-intervention-for-schizophrenia-spectrum-disorders-122404https://curecurrent.com/trials/comparison-of-physical-fitness-physical-activity-level-in-patients-with-bipolar-disorder-and-schizophrenia-122405https://curecurrent.com/trials/the-efficacy-of-speech-competition-training-on-auditory-hallucination-in-schizophrenia-122406https://curecurrent.com/trials/prevalence-of-traumatic-events-and-ptsd-in-immigrant-and-non-immigrant-patients-with-psychotic-disorder-122407https://curecurrent.com/trials/cognitive-training-for-patients-with-schizophrenia-122408https://curecurrent.com/trials/evaluation-of-physical-activity-physical-fitness-and-quality-of-life-in-patients-with-schizophrenia-122409https://curecurrent.com/trials/a-study-to-evaluate-iloperidone-long-acting-injection-lai-for-the-treatment-of-schizophrenia-122410https://curecurrent.com/trials/cognitive-effects-of-nimodipine-in-patients-with-schizophrenia-122411https://curecurrent.com/trials/novel-pharmacotherapy-approaches-in-smokers-with-serious-mental-illness-122412https://curecurrent.com/trials/optimal-rtms-for-cognitive-deficits-and-negative-symptoms-in-schizophrenia-122413https://curecurrent.com/trials/clinical-interviews-with-detainees-with-early-psychosis-122414https://curecurrent.com/trials/on-track-chile-for-first-episode-psychosis-122415https://curecurrent.com/trials/trial-to-investigate-the-safety-and-efficacy-of-gwp42003-p-versus-placebo-as-adjunctive-therapy-in-participants-with-sch-122416https://curecurrent.com/trials/prebiotic-treatment-in-people-with-schizophrenia-pilot-study-122417https://curecurrent.com/trials/brain-health-and-exercise-in-schizophrenia-122418https://curecurrent.com/trials/a-smartphone-app-on-medication-adherence-122419https://curecurrent.com/trials/online-tp-training-program-on-sc-social-cognition-for-schizophrenia-122420https://curecurrent.com/trials/music-therapy-for-people-with-schizophrenia-and-relates-psychosis-122421https://curecurrent.com/trials/the-motor-neurological-soft-signs-mnss-in-persons-with-schizophrenia-122422https://curecurrent.com/trials/efficacy-study-of-a-new-individualized-rehabilitation-programme-for-social-cognition-in-patients-with-schizophrenia-122423https://curecurrent.com/trials/a-study-of-the-efficacy-of-fecal-microbiota-transplantation-fmt-in-the-treatment-of-schizophrenia-122424https://curecurrent.com/trials/an-in-depth-study-evaluating-the-experiences-of-patients-in-schizophrenia-research-122425https://curecurrent.com/trials/dance-and-movement-therapy-in-patients-with-schizophrenia-122426https://curecurrent.com/trials/physical-activity-psychopathology-and-quality-of-life-in-people-with-psychotic-or-affective-disorders-122427https://curecurrent.com/trials/bioequivalence-study-in-patients-with-schizophrenia-by-using-clozaril-100-mg-tablet-clozapine-and-wid-clz18-122428https://curecurrent.com/trials/acceptability-and-feasibility-of-mol-in-acute-inpatient-units-122429https://curecurrent.com/trials/hjernegym-effects-of-exergaming-in-psychosis-a-clinical-intervention-study-122430https://curecurrent.com/trials/treatment-of-cognitive-and-negative-symptoms-in-schizophrenia-with-n-acetylcysteine-122431https://curecurrent.com/trials/metacognitive-training-as-a-serious-game-122432https://curecurrent.com/trials/cognitive-approaches-to-combatting-suicidality-122433https://curecurrent.com/trials/melatonin-effects-on-sleep-and-circadian-rhythm-in-youth-and-young-adults-with-at-risk-symptoms-122434https://curecurrent.com/trials/observational-study-on-the-effect-of-switch-to-lurasidone-in-subjects-with-schizophrenia-122435https://curecurrent.com/trials/pharmacogenetics-and-therapeutic-drug-monitoring-in-schizophrenia-122436https://curecurrent.com/trials/vr-assisted-cbt-for-adolescents-with-psychosis-122437https://curecurrent.com/trials/study-to-evaluate-efficacy-and-safety-of-roluperidone-min-101-in-adult-patients-with-negative-symptoms-of-schizophrenia-122438https://curecurrent.com/trials/theory-based-integrated-program-on-medication-adherence-among-community-dwelling-schizophrenia-122439https://curecurrent.com/trials/a-6-month-study-to-evaluate-sulforaphane-effects-in-schizophrenia-patients-122440https://curecurrent.com/trials/relative-bioavailability-of-ly03010-compared-to-listed-drug-122441https://curecurrent.com/trials/cognitive-behavioral-suicide-prevention-for-psychosis-aim-1-122442https://curecurrent.com/trials/the-efficacy-of-auricular-acupressure-on-improving-constipation-among-residents-in-community-rehabilitation-center-122443https://curecurrent.com/trials/enhancing-educational-and-vocational-recovery-in-adolescents-and-young-adults-with-early-psychosis-through-supported-emp-122444https://curecurrent.com/trials/effects-of-glyx-13-on-learning-and-memory-in-healthy-individuals-and-those-with-psychiatric-illness-122445https://curecurrent.com/trials/a-12-weeks-study-to-evaluate-the-dietary-fiber-and-probiotics-treatment-in-prevention-and-intervention-of-weight-gain-an-122446https://curecurrent.com/trials/rtms-in-first-episode-psychosis-122447https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-biib104-in-participants-with-cognitive-impairment-associated-with-schizop-122448https://curecurrent.com/trials/clinical-intervention-on-cognitive-impairment-of-schizophrenia-with-metabolic-syndrome-122449https://curecurrent.com/trials/neuroinflammation-markers-in-subjects-with-psychotic-symptoms-122450https://curecurrent.com/trials/verbal-memory-training-using-virtual-reality-in-schizophrenia-122451https://curecurrent.com/trials/improving-cognition-via-exercise-in-schizophrenia-122452https://curecurrent.com/trials/study-of-experience-of-high-frequency-repetitive-transcranial-122453https://curecurrent.com/trials/intra-cortical-inhibition-and-cognitive-deficits-in-schizophrenia-122454https://curecurrent.com/trials/metformin-treatment-on-cognitive-impairment-of-schizophrenia-co-morbid-metabolic-syndrome-122455https://curecurrent.com/trials/safety-and-efficacy-of-virtual-reality-mindfulness-in-patients-with-psychosis-122456https://curecurrent.com/trials/pilot-study-of-motivational-interviewing-for-loved-ones-122457https://curecurrent.com/trials/analysis-of-parameters-indicating-the-intensity-of-suicidal-behavior-in-psychiatric-patients-122458https://curecurrent.com/trials/a-study-of-olanzapine-in-patients-with-acute-agitation-122459https://curecurrent.com/trials/clinical-risk-state-for-bipolar-disorder-in-adolescents-122460https://curecurrent.com/trials/tdcs-for-cognitive-impairment-associated-with-recent-onset-schizophrenia-122461https://curecurrent.com/trials/a-study-measuring-effect-of-ly2140023-pomaglumetad-methionil-on-electrocardiographs-in-participants-with-schizophrenia-122462https://curecurrent.com/trials/group-cognitive-behavioural-family-intervention-cbfi-for-people-with-schizophrenia-and-their-families-122463https://curecurrent.com/trials/discriminant-validity-of-the-multiple-errands-test-in-schizophrenia-122464https://curecurrent.com/trials/cognitive-remediation-method-by-rhythmic-vocal-and-embodied-musical-learning-for-stabilized-schizophrenic-patients-122465https://curecurrent.com/trials/depth-of-anesthesia-during-electroconvulsive-therapy-122466https://curecurrent.com/trials/ziprasidone-in-the-psychosis-prodrome-122467https://curecurrent.com/trials/skills-training-to-enhance-vocational-outcomes-in-veterans-with-serious-mental-illness-122468https://curecurrent.com/trials/linguistic-predictors-of-outcomes-in-psychosis-122469https://curecurrent.com/trials/stimulating-the-brain-to-improve-self-awareness-122470https://curecurrent.com/trials/impact-of-structural-and-myelin-abnormalities-on-cognitive-impairments-in-recent-onset-schizophrenia-before-and-after-lu-122471https://curecurrent.com/trials/bridging-gaps-in-the-neuroimaging-puzzle-new-ways-to-image-brain-anatomy-and-function-in-health-and-disease-using-electr-122472https://curecurrent.com/trials/program-for-the-introduction-into-clinical-practice-of-the-principles-of-personalized-and-preventive-medicine-based-on-t-122473https://curecurrent.com/trials/randomized-controlled-trial-of-pyridoxine-for-tardive-dyskinesia-122474https://curecurrent.com/trials/tdcs-and-cognitive-training-intervention-for-chronic-smokers-with-schizophrenia-122475https://curecurrent.com/trials/cardiac-rehabilitation-for-cardiovascular-risk-reduction-in-people-with-severe-and-persistent-mental-illness-122476https://curecurrent.com/trials/patient-generated-goals-in-mental-health-better-outcomes-122477https://curecurrent.com/trials/study-to-evaluate-tv-46000-as-maintenance-treatment-in-adult-and-adolescent-participants-with-schizophrenia-122478https://curecurrent.com/trials/effectiveness-of-behavioral-activation-treatment-for-schizophrenia-122479https://curecurrent.com/trials/a-study-of-hs-10380-in-chinese-participants-122480https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-and-cognitive-processing-122481https://curecurrent.com/trials/efficacy-of-computer-assisted-cognitive-remediation-in-patients-with-schizophrenia-122482https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-tdcs-on-motor-function-in-schizophrenia-patients-and-individuals-at-r-122483https://curecurrent.com/trials/intervention-to-decrease-the-stigma-of-nursing-students-122484https://curecurrent.com/trials/oral-versus-injectable-risperidone-for-treating-first-episode-schizophrenia-122485https://curecurrent.com/trials/faah-availability-in-psychiatric-disorders-a-pet-study-122486https://curecurrent.com/trials/the-impact-of-gaming-on-functioning-among-people-with-schizophrenia-122487https://curecurrent.com/trials/cbt-i-for-psychosis-guidelines-preliminary-efficacy-and-functional-outcomes-122488https://curecurrent.com/trials/overcoming-psychomotor-slowing-in-psychosis-ocops-p-122489https://curecurrent.com/trials/targeting-individual-alpha-frequencies-to-enhance-perceptual-timing-122490https://curecurrent.com/trials/placebo-controlled-trial-in-subjects-at-ultra-high-risk-for-psychosis-with-omega-3-fatty-acids-in-europe-122491https://curecurrent.com/trials/mindfulness-based-group-therapy-for-inpatients-with-schizophrenia-spectrum-disorders-122492https://curecurrent.com/trials/pilot-the-use-of-va-make-the-connection-campaign-to-facilitate-help-seeking-among-vulnerable-veterans-122493https://curecurrent.com/trials/a-multiple-dose-study-to-assess-the-safety-tolerability-and-pk-of-risperidone-extended-release-capsules-122494https://curecurrent.com/trials/a-6-week-study-to-evaluate-the-efficacy-and-safety-of-lurasidone-hcl-in-acutely-psychotic-patients-with-schizophrenia-122495https://curecurrent.com/trials/emove-dance-movement-therapy-study-122496https://curecurrent.com/trials/observational-study-of-long-acting-injectable-medications-lais-in-schizophrenia-oasis-122497https://curecurrent.com/trials/biomarker-and-safety-study-of-clozapine-in-patients-with-benign-ethnic-neutropenia-ben-122498https://curecurrent.com/trials/a-study-of-cognitive-adaptation-training-in-inpatient-forensic-environments-122499https://curecurrent.com/trials/well-being-and-resilience-mechanisms-of-transmission-of-health-and-risk-122500https://curecurrent.com/trials/tdcs-combined-with-rtms-for-negative-symptoms-of-schizophrenia-122501https://curecurrent.com/trials/hippocampus-dbs-in-treatment-resistant-schizophrenia-122502https://curecurrent.com/trials/mobile-after-care-intervention-to-support-post-hospital-transition-macs-122503https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-alks-3831-on-body-weight-in-young-adults-who-have-been-recently-diagnosed-with-schizop-122504https://curecurrent.com/trials/circuitry-guided-smoking-cessation-in-schizophrenia-122505https://curecurrent.com/trials/game-based-telehealth-therapeutic-intervention-in-first-onset-psychosis-122506https://curecurrent.com/trials/inmotion-physical-training-with-creative-movement-as-an-intervention-for-adults-with-schizophrenia-122507https://curecurrent.com/trials/implementation-of-family-involvement-for-persons-with-psychotic-disorders-122508https://curecurrent.com/trials/targeting-cerebellum-to-treat-psychosis-a-transcranial-magnetic-stimulation-tms-study-122509https://curecurrent.com/trials/restoration-of-cognitive-function-with-tdcs-and-training-in-serious-mental-illness-122510https://curecurrent.com/trials/memantine-effects-on-sensorimotor-gating-and-neurocognition-in-schizophrenia-122511https://curecurrent.com/trials/treatment-of-negative-symptoms-and-schizophrenia-122512https://curecurrent.com/trials/trial-to-study-the-effect-of-cvl-231-on-24-hour-ambulatory-blood-pressure-in-participants-with-schizophrenia-122513https://curecurrent.com/trials/planning-your-everyday-life-in-virtual-reality-a-study-in-schizophrenia-122514https://curecurrent.com/trials/a-study-on-the-efficacy-of-agomelatine-combined-with-antipsychotics-to-treat-negative-symptoms-in-schizophrenia-122515https://curecurrent.com/trials/a-study-to-test-if-tv-46000-is-safe-for-maintenance-treatment-of-schizophrenia-122516https://curecurrent.com/trials/effects-of-delta-9-thc-and-iomazenil-in-healthy-humans-122517https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-lumateperone-long-acting-injectable-in-patients-with-schizophrenia-122518https://curecurrent.com/trials/targeted-cognitive-training-in-clinical-high-risk-chr-for-psychosis-122519https://curecurrent.com/trials/a-placebo-controlled-efficacy-study-of-iv-ceftriaxone-for-refractory-psychosis-122520https://curecurrent.com/trials/rt-fmri-neurofeedback-and-ah-in-schizophrenia-122521https://curecurrent.com/trials/attachment-focused-imagery-therapy-for-psychosis-a-imaps-122522https://curecurrent.com/trials/resting-state-electroencephalogram-for-psychotic-disorders-122523https://curecurrent.com/trials/accelerated-ctbs-on-metabolic-dysfunction-in-people-with-schizophrenia-122524https://curecurrent.com/trials/levetiracetam-in-early-psychosis-122525https://curecurrent.com/trials/non-interventional-study-in-bipolar-disorder-and-schizophrenia-with-zeldox-122526https://curecurrent.com/trials/ctbs-on-first-episode-drug-naive-patients-with-schizophrenia-122527https://curecurrent.com/trials/rtms-on-appetite-and-cognitive-function-in-schizophrenia-122528https://curecurrent.com/trials/the-impact-of-caffeine-on-cognition-in-schizophrenia-122529https://curecurrent.com/trials/a-safety-and-pk-study-of-injectable-risperidone-saber-and-the-dosepro-delivery-system-in-patients-with-schizophrenia-122530https://curecurrent.com/trials/a-safety-study-comparing-ly2140023-to-atypical-antipsychotic-standard-treatment-in-schizophrenic-patients-122531https://curecurrent.com/trials/just-do-you-program-for-young-adults-with-serious-mental-iilness-122532https://curecurrent.com/trials/ascertaining-diagnosis-classification-with-elicited-speech-122533https://curecurrent.com/trials/cog-psycho-social-cognition-and-psychotic-characteristics-genetic-and-phenomic-approach-122534https://curecurrent.com/trials/safety-and-pk-trial-with-injectable-zx003-risperidone-saber-compared-to-risperdal-consta-in-stable-schizophrenia-122535https://curecurrent.com/trials/cognitive-impairments-in-psychotic-disorders-122536https://curecurrent.com/trials/evaluation-of-the-role-of-neurodegeneration-in-schizophrenia-122537https://curecurrent.com/trials/prolactin-change-in-chinese-patients-with-schizophrenia-after-antipsychotics-treatment-122538https://curecurrent.com/trials/intervention-effect-of-shen-based-qigong-exercise-on-residual-symptoms-of-schizophrenia-122539https://curecurrent.com/trials/manualized-group-cognitive-behavioral-therapy-for-social-anxiety-in-first-episode-psychosis-122540https://curecurrent.com/trials/pentoxifylline-as-an-adjunctive-in-treatment-of-negative-symptoms-in-chronic-schizophrenia-122541https://curecurrent.com/trials/group-cognitive-behavioral-intervention-for-social-anxiety-in-schizophrenia-122542https://curecurrent.com/trials/a-study-of-ly2140023-in-patients-with-schizophrenia-122543https://curecurrent.com/trials/families-with-substance-use-and-psychosis-a-pilot-study-122544https://curecurrent.com/trials/examining-dose-related-effects-of-oxytocin-on-social-cognition-across-populations-122545https://curecurrent.com/trials/exercise-target-brain-oscillations-in-psychosis-122546https://curecurrent.com/trials/efficacy-of-tacs-for-treatment-of-auditory-hallucinations-in-refractory-schizophrenia-122547https://curecurrent.com/trials/biomarker-strategies-for-medication-enhanced-cognitive-training-in-schizophrenia-122548https://curecurrent.com/trials/metacognitive-intervention-for-individuals-with-severe-mental-disorders-122549https://curecurrent.com/trials/young-people-and-illness-management-and-recovery-imr-122550https://curecurrent.com/trials/oxytocin-and-social-decision-making-in-schizophrenia-122551https://curecurrent.com/trials/prevalence-of-sialorrhea-in-patients-treated-with-clozapine-122552https://curecurrent.com/trials/targeted-self-management-for-epilepsy-and-serious-mental-illness-time-122553https://curecurrent.com/trials/insomnia-in-the-patient-with-schizophrenic-disorder-evaluation-of-a-cbt-and-psychoeducational-intervention-122554https://curecurrent.com/trials/a-study-of-gwp42003-as-adjunctive-therapy-in-the-first-line-treatment-of-schizophrenia-or-related-psychotic-disorder-122555https://curecurrent.com/trials/longitudinal-multimodal-neuroimaging-studies-in-patients-with-first-episode-psychosis-122556https://curecurrent.com/trials/a-12-month-observational-prospective-cohort-study-to-analyze-cardiometabolic-profile-changes-to-switch-to-lurasidone-in-122557https://curecurrent.com/trials/targeting-physical-health-in-schizophrenia-physical-activity-can-enhance-life-randomized-control-trial-122558https://curecurrent.com/trials/mechanisms-of-cognitive-change-122559https://curecurrent.com/trials/a-study-of-safety-and-tolerability-in-subjects-with-schizophrenia-122560https://curecurrent.com/trials/a-physical-dependence-study-in-schizophrenia-122561https://curecurrent.com/trials/the-role-of-dysmyelination-in-cognitive-impairment-of-psychotic-spectrum-disorders-122562https://curecurrent.com/trials/persistence-targeted-smoking-cessation-in-serious-mental-illness-smi-122563https://curecurrent.com/trials/the-effect-of-d-serine-as-add-on-therapy-in-recent-onset-psychosis-122564https://curecurrent.com/trials/a-comparison-study-of-ly2140023-and-aripiprazole-in-schizophrenia-patients-122565https://curecurrent.com/trials/a-study-of-ly2140023-in-schizophrenia-patients-with-prominent-negative-symptoms-122566https://curecurrent.com/trials/covid-19-serological-testing-of-patients-with-a-mental-disorder-from-the-catchment-area-of-the-capital-region-of-denmark-122567https://curecurrent.com/trials/disturbance-of-plasma-cytokine-parameters-in-clozapine-resistant-treatment-refractory-schizophrenia-ctrs-and-their-assoc-122568https://curecurrent.com/trials/cannabidiol-treatment-in-patients-with-early-psychosis-122569https://curecurrent.com/trials/alpha-lipoic-acid-adjunctive-therapy-in-schizophrenia-122570https://curecurrent.com/trials/effect-of-tdcs-on-cognition-symptoms-in-chronic-schizophrenia-patients-with-tardive-dyskinesia-122571https://curecurrent.com/trials/carnosine-and-cognitive-training-in-schizophrenia-122572https://curecurrent.com/trials/basic-auditory-processing-and-auditory-hallucinations-122573https://curecurrent.com/trials/risk-prediction-model-of-cardiovascular-events-in-patients-with-schizophrenia-122574https://curecurrent.com/trials/rc2s-remediation-of-social-cognitive-impairments-122575https://curecurrent.com/trials/cognitive-enhancement-on-working-memory-in-patients-with-schizophrenia-122576https://curecurrent.com/trials/transcranial-direct-and-alternating-stimulation-of-the-prefrontal-cortex-for-cognitive-improvement-in-schizophrenia-122577https://curecurrent.com/trials/mindfulness-empathy-and-the-oxytocinergic-system-in-persons-with-schizophrenia-122578https://curecurrent.com/trials/efficacy-of-isst-in-schizophrenia-122579https://curecurrent.com/trials/non-pharmacological-treatment-of-psychosis-122580https://curecurrent.com/trials/the-norwegian-prednisolone-in-early-psychosis-study-122581https://curecurrent.com/trials/museum-based-group-art-therapy-in-mental-health-recovery-122582https://curecurrent.com/trials/improving-accessibility-and-personalization-of-cr-for-schizophrenia-122583https://curecurrent.com/trials/itbs-can-increase-frontal-dopamine-release-in-pet-dopamine-imaging-122584https://curecurrent.com/trials/non-invasive-direct-current-stimulation-for-cognition-in-schizophrenia-122585https://curecurrent.com/trials/retrieval-practice-and-schizophrenia-122586https://curecurrent.com/trials/magnetic-seizure-therapy-versus-electroconvulsive-therapy-for-schizophrenia-122587https://curecurrent.com/trials/computerized-cognitive-remediation-therapy-in-adolescents-with-a-first-psychotic-episode-122588https://curecurrent.com/trials/online-yoga-and-the-impact-on-psychosis-122589https://curecurrent.com/trials/d-serine-augmentation-of-neuroplasticity-122590https://curecurrent.com/trials/role-functioning-changes-nos-122591https://curecurrent.com/trials/effects-of-galantamine-on-cognition-122592https://curecurrent.com/trials/cognitive-training-delivered-remotely-to-individuals-with-psychosis-roam-122593https://curecurrent.com/trials/minimizing-doses-of-antipsychotic-medication-in-older-patients-with-schizophrenia-122594https://curecurrent.com/trials/response-to-clozapine-in-treatment-resistant-schizophrenia-a-longitudinal-magnetic-resonance-spectroscopy-study-122595https://curecurrent.com/trials/effectiveness-and-mechanisms-of-recovery-oriented-cognitive-therapy-122596https://curecurrent.com/trials/the-role-of-group-identity-on-the-community-integration-of-people-with-severe-mental-disorder-122597https://curecurrent.com/trials/video-games-among-people-with-schizophrenia-122598https://curecurrent.com/trials/online-exercise-intervention-for-psychosis-patients-receiving-residential-care-122599https://curecurrent.com/trials/effects-of-rhythmic-auditory-stimulation-on-movements-in-individuals-at-risk-for-psychotic-onset-and-schizophrenia-patie-122600https://curecurrent.com/trials/research-into-antipsychotic-discontinuation-and-reduction-trial-122601https://curecurrent.com/trials/recovery-from-paranoia-a-qualitative-exploration-122602https://curecurrent.com/trials/tms-in-treatment-of-schizophrenia-negative-symptoms-122603https://curecurrent.com/trials/targeted-pharmacological-and-behavioral-treatments-for-smoking-in-schizophrenia-study-1-122604https://curecurrent.com/trials/multimodal-prevention-of-psychosis-investigating-efficacy-of-n-acetylcysteine-and-psychotherapy-in-chr-patients-122605https://curecurrent.com/trials/magnetic-seizure-therapy-for-schizophrenia-122606https://curecurrent.com/trials/intervention-to-improve-coping-with-negative-emotions-in-patients-with-psychosis-feel-good-study-122607https://curecurrent.com/trials/enhancing-cognitive-reserve-of-the-offsprings-of-bipolar-and-schizophrenic-patients-122608https://curecurrent.com/trials/receptor-occupancy-of-lb-102-using-positron-emission-tomography-pet-in-healthy-volunteers-122609https://curecurrent.com/trials/pilot-study-to-evaluate-the-effectiveness-of-online-familiar-metacognitive-training-mctf-122610https://curecurrent.com/trials/an-observational-study-on-metabolic-syndrome-parameters-in-schizophrenia-patients-treated-with-atypical-antipsychotics-122611https://curecurrent.com/trials/study-evaluating-safety-and-tolerability-of-ascending-multiple-dose-of-slv-313-in-schizophrenia-patients-122612https://curecurrent.com/trials/csc-ondemand-an-innovative-online-learning-platform-for-implementing-coordinated-specialty-care-122613https://curecurrent.com/trials/minocycline-augmentation-of-clozapine-for-treatment-resistant-schizophrenia-122614https://curecurrent.com/trials/effects-of-transdermal-nicotine-on-response-inhibition-to-emotional-cues-in-schizophrenia-122615https://curecurrent.com/trials/a-clinical-pharmacology-trial-of-brexpiprazole-long-acting-injectable-lai-administered-as-a-single-dose-in-patients-with-122616https://curecurrent.com/trials/sodium-benzoate-and-or-n-acetylcysteine-added-to-tau-in-patients-with-early-schizophrenia-spectrum-disorder-122617https://curecurrent.com/trials/pharmacokinetics-of-cvl-231-following-single-oral-administration-of-modified-and-immediate-release-formulations-in-faste-122618https://curecurrent.com/trials/safety-biomarker-study-of-rl-007-in-subjects-with-schizophrenia-122619https://curecurrent.com/trials/sensitivity-threshold-tolerance-and-pain-recognition-in-schizophrenia-patients-and-their-relatives-122620https://curecurrent.com/trials/a-study-of-the-safety-pk-and-exploratory-efficacy-of-sp-624-in-acutely-psychotic-adult-subjects-with-schizophrenia-122621https://curecurrent.com/trials/reproductive-life-planning-for-women-with-mental-illness-122622https://curecurrent.com/trials/step-ed-reducing-duration-of-untreated-psychosis-and-its-impact-in-the-u-s-122623https://curecurrent.com/trials/aripiprazole-once-monthly-in-hospitalized-patients-initiate-122624https://curecurrent.com/trials/cognitive-remediation-plus-aerobic-exercise-in-schizophrenia-treatment-122625https://curecurrent.com/trials/effects-of-ketamine-on-mentalizing-and-metacognition-in-healthy-volunteers-122626https://curecurrent.com/trials/psychometric-validation-of-an-oral-health-related-scale-for-quality-of-life-and-coping-in-people-with-schizophrenia-122627https://curecurrent.com/trials/application-of-up-for-transdiagnostic-treatment-of-emotional-disorders-for-uhr-for-psychosis-patients-122628https://curecurrent.com/trials/effects-of-an-integrated-multimodal-lifestyle-intervention-for-management-of-violence-in-schizophrenia-122629https://curecurrent.com/trials/soft-tissue-tenderness-and-fibromyalgia-among-schizophrenia-patients-122630https://curecurrent.com/trials/the-effect-of-progressive-muscle-relaxation-on-psychological-symptoms-and-mental-well-being-in-patients-with-schizophren-122631https://curecurrent.com/trials/study-assessing-the-safety-tolerability-and-pharmacokinetics-of-sep-363856-in-japanese-male-and-female-subjects-with-sch-122632https://curecurrent.com/trials/long-term-extension-study-of-sm-13496-lurasidone-hcl-in-patients-with-schizophrenia-122633https://curecurrent.com/trials/study-of-sm-13496-lurasidone-hcl-in-patients-with-schizophrenia-122634https://curecurrent.com/trials/long-term-study-of-dsp-5423p-in-patients-with-schizophrenia-122635https://curecurrent.com/trials/study-assessing-the-safety-tolerability-and-pharmacokinetics-of-sep-363856-in-japanese-male-and-female-subjects-with-sch-122636https://curecurrent.com/trials/confirmatory-study-of-dsp-5423p-in-patients-with-schizophrenia-122637https://curecurrent.com/trials/a-phase-iii-study-of-sm-13496-lurasidone-hcl-in-patients-with-schizophrenia-122638https://curecurrent.com/trials/clinical-trial-evaluating-the-efficacy-safety-and-tolerability-of-cariprazine-in-a-dose-reduction-paradigm-in-the-preven-122639https://curecurrent.com/trials/oral-risperidone-versus-injectable-paliperidone-palmitate-for-treating-first-episode-schizophrenia-122640https://curecurrent.com/trials/the-efficacy-of-using-a-smartphone-app-to-support-shared-decision-making-in-people-with-a-diagnosis-of-schizophrenia-122641https://curecurrent.com/trials/virtual-reality-assisted-cbt-for-social-difficulties-a-feasibility-study-in-early-intervention-for-psychosis-services-122642https://curecurrent.com/trials/antipsychotic-effects-of-probiotics-and-prebiotics-on-patients-with-schizophrenia-122643https://curecurrent.com/trials/eeg-based-neurofeedback-for-auditory-verbal-hallucinations-halfeed-122644https://curecurrent.com/trials/mechanistic-clinical-trial-of-individualized-tdcs-for-hallucinations-in-schizophrenia-122645https://curecurrent.com/trials/multicenter-randomized-comparative-and-prospective-study-evaluating-the-impact-on-the-care-path-of-an-editorial-program-122646https://curecurrent.com/trials/effect-of-nicotine-transdermal-patch-on-cognitive-function-and-glycolipid-metabolism-in-non-smoking-schizophrenia-122647https://curecurrent.com/trials/study-of-the-effectiveness-of-mental-contrasting-and-implementation-intention-in-the-management-of-apathy-in-schizophren-122648https://curecurrent.com/trials/cognitive-remediation-and-social-recovery-in-early-psychosis-122649https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-risperidone-ism-in-patients-with-acute-schizophrenia-open-label-extension-122650https://curecurrent.com/trials/implementation-of-a-social-and-mental-health-support-to-promote-recovery-in-five-mental-health-facilities-in-paris-area-122651https://curecurrent.com/trials/source-monitoring-psychosis-122652https://curecurrent.com/trials/a-mobile-application-to-improve-case-management-and-patient-s-functioning-in-first-episode-psychosis-122653https://curecurrent.com/trials/a-controlled-study-with-remote-web-based-adapted-physical-activity-e-apa-in-psychotic-disorders-122654https://curecurrent.com/trials/treating-early-stages-with-an-intervention-targeting-cognitive-reserve-122655https://curecurrent.com/trials/comparison-of-varenicline-and-placebo-for-smoking-cessation-in-schizophrenia-122656https://curecurrent.com/trials/long-acting-paliperidone-in-dually-diagnosed-people-with-schizophrenia-an-open-label-pilot-study-122657https://curecurrent.com/trials/an-open-label-investigation-of-the-adjuvant-therapeutic-effects-of-galantamine-in-patients-with-chronic-schizophrenia-an-122658https://curecurrent.com/trials/implementation-efficacy-and-costs-of-inpatient-equivalent-home-treatment-in-german-mental-health-care-122659https://curecurrent.com/trials/atomoxetine-for-treatment-of-weight-gain-in-olanzapine-or-clozapine-patients-122660https://curecurrent.com/trials/effect-of-individual-cognitive-stimulation-at-home-in-adults-with-psychotic-disorders-122661https://curecurrent.com/trials/pharmacogenetics-of-cannabinoid-response-122662https://curecurrent.com/trials/treating-social-cognition-with-theta-burst-stimulation-a-multicentric-study-122663https://curecurrent.com/trials/cannabinoids-neural-synchrony-and-information-processing-122664https://curecurrent.com/trials/the-effects-of-9-thc-and-naloxone-in-humans-122665https://curecurrent.com/trials/anti-inflammatory-treatment-of-schizophrenia-122666https://curecurrent.com/trials/aerobic-exercise-for-the-improvement-of-cognition-and-enhancement-of-recovery-in-post-acute-schizophrenia-122667https://curecurrent.com/trials/the-effect-of-psychoeducation-on-healthy-lifestyle-behaviors-in-individuals-with-schizophrenia-122668https://curecurrent.com/trials/the-difference-of-grey-matter-volume-among-the-patients-of-schizophrenia-122669https://curecurrent.com/trials/telmisartan-pilot-study-on-treatment-resistant-schizophrenia-122670https://curecurrent.com/trials/testing-the-interactive-effects-of-delta-9-tetrahydrocannabinol-and-pregnenolone-sub-study-i-122671https://curecurrent.com/trials/improving-psychological-therapy-for-psychosis-a-case-series-122672https://curecurrent.com/trials/ginkgo-biloba-extract-in-the-treatment-of-schizophrenia-122673https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-risperidone-in-situ-microparticle-ism-in-patients-with-acute-schizophrenia-122674https://curecurrent.com/trials/the-association-of-affective-resonance-with-empathy-modulated-by-negative-symptomatology-and-oxytocin-122675https://curecurrent.com/trials/behavioral-treatment-of-drug-abuse-in-severe-and-persistent-mental-illness-spmi-patients-122676https://curecurrent.com/trials/targeting-auditory-hallucinations-with-alternating-current-stimulation-122677https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-using-an-active-control-in-subjects-with-schizophrenia-or-schizoaffective-disorder-2552-122678https://curecurrent.com/trials/comparison-of-berberine-and-metformin-for-the-treatment-for-ms-in-schizophrenia-patients-122679https://curecurrent.com/trials/long-term-efficacy-and-safety-of-asenapine-using-olanzapine-as-a-positive-control-41512-completed-p05784-122680https://curecurrent.com/trials/abilify-maintena-pms-in-schizophrenia-patients-or-bipolar-1-disorder-122681https://curecurrent.com/trials/assessment-of-the-efficacy-of-a-fatigue-management-therapy-in-schizophrenia-122682https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-clinical-trial-of-jx11502ma-capsule-122683https://curecurrent.com/trials/the-effect-of-psychoeducation-program-on-healthy-living-behaviors-122684https://curecurrent.com/trials/6-month-extension-trial-of-asenapine-with-olanzapine-in-negative-symptoms-patients-who-completed-the-first-6-month-trial-122685https://curecurrent.com/trials/study-of-asenapine-in-elderly-subjects-with-psychosis-a7501021-p05717-122686https://curecurrent.com/trials/a-trial-to-determine-whether-two-differing-strength-tablets-3-x-5-mg-versus-1-x-15-mg-of-sublingually-org-5222-asenapine-122687https://curecurrent.com/trials/6-month-extension-trial-of-asenapine-with-olanzapine-in-negative-symptom-patients-who-completed-the-protocol-25543-25544-122688https://curecurrent.com/trials/long-term-efficacy-and-safety-of-asenapine-using-haloperidol-as-a-positive-control-41513-completed-p05785-122689https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-compared-with-olanzapine-in-patients-with-persistent-negative-symptoms-of-schizophrenia-122690https://curecurrent.com/trials/to-determine-long-term-efficacy-and-safety-of-asenapine-in-schizophrenic-patient-population-a7501012-completed-p05770-122691https://curecurrent.com/trials/family-psychoeducation-for-adults-with-psychotic-disorders-in-tanzania-122692https://curecurrent.com/trials/post-authorization-safety-surveillance-study-of-asenapine-in-participants-with-bipolar-disorder-p08307-122693https://curecurrent.com/trials/prevalence-of-cardiovascular-disorders-in-patients-aged-40-and-more-with-schizophrenia-122694https://curecurrent.com/trials/the-effects-of-cannabidiol-and-9-thc-in-humans-122695https://curecurrent.com/trials/n-acetylcysteine-effects-on-tetrahydrocannabinol-122696https://curecurrent.com/trials/social-cognitive-assessment-in-autism-and-schizophrenia-122697https://curecurrent.com/trials/effects-of-integrated-moral-reasoning-development-intervention-for-management-of-violence-in-schizophrenia-122698https://curecurrent.com/trials/l-arginine-study-for-persistent-symptoms-of-schizophrenia-122699https://curecurrent.com/trials/exenatide-weekly-injections-as-an-adjunctive-treatment-in-patients-with-schizophrenia-122700https://curecurrent.com/trials/evaluate-the-safety-tolerability-and-pharmacokinetic-profile-of-tpn672-tablets-maleate-in-patients-with-schizophrenia-122701https://curecurrent.com/trials/oxytocin-or-galantamine-versus-placebo-for-the-treatment-of-negative-symptoms-and-cognitive-impairments-in-schizophrenia-122702https://curecurrent.com/trials/the-efficacy-of-computerized-cognitive-remediation-therapy-for-chronic-schizophrenia-122703https://curecurrent.com/trials/treatment-of-schizophrenia-with-l-tetrahydropalmatine-l-thp-a-novel-dopamine-antagonist-with-anti-inflammatory-and-antip-122704https://curecurrent.com/trials/minocycline-and-tobacco-craving-in-smokers-with-schizophrenia-122705https://curecurrent.com/trials/comparative-bioavailability-of-risperidone-122706https://curecurrent.com/trials/varenicline-adjunctive-treatment-in-schizophrenia-122707https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-wid-rgc20-cariprazine-in-patients-with-schizophrenia-122708https://curecurrent.com/trials/exploration-of-the-deep-transcranial-magnetic-stimulation-for-treatment-resistant-schizophrenia-122709https://curecurrent.com/trials/maintain-the-efficacy-and-safety-in-treatment-of-schizophrenia-after-switching-to-long-acting-injectable-aripiprazole-fr-122710https://curecurrent.com/trials/transcranial-alternating-current-stimulation-tacs-for-auditory-hallucinations-122711https://curecurrent.com/trials/comparative-bioavailability-of-risperidone-122712https://curecurrent.com/trials/study-of-cad-9303-in-subjects-with-schizophrenia-122713https://curecurrent.com/trials/illness-management-and-recovery-for-veterans-with-severe-mental-illness-122714https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-the-treatment-of-auditory-hallucinations-in-schizophrenia-122715https://curecurrent.com/trials/glutamate-reducing-interventions-in-schizophrenia-122716https://curecurrent.com/trials/ontrack-an-online-role-playing-game-for-young-people-with-first-episode-psychosis-122717https://curecurrent.com/trials/efficacy-of-chronic-disease-self-management-program-in-people-with-schizophrenia-122718https://curecurrent.com/trials/the-synergistic-effect-of-hypoglycemic-index-diet-on-refractory-schizophrenia-122719https://curecurrent.com/trials/the-impact-of-the-covid-19-pandemic-on-schizophrenia-patients-registered-with-the-community-mental-health-center-122720https://curecurrent.com/trials/iti-007-lumateperone-tosylate-for-schizophrenia-122721https://curecurrent.com/trials/improving-adherence-to-cognitive-rehabilitation-122722https://curecurrent.com/trials/animal-assisted-therapy-in-the-residential-treatment-of-schizophrenia-and-addictions-122723https://curecurrent.com/trials/evaluation-of-a-mindfulness-resiliency-training-program-for-refugees-living-in-jordan-122724https://curecurrent.com/trials/an-integrated-program-for-the-treatment-of-first-episode-of-psychosis-122725https://curecurrent.com/trials/psychodynamic-psychotherapy-for-psychosis-122726https://curecurrent.com/trials/multiple-ascending-doses-of-pf-04958242-in-subjects-with-stable-schizophrenia-122727https://curecurrent.com/trials/clozapine-use-pattern-in-the-province-of-seville-122728https://curecurrent.com/trials/reducing-the-burden-of-chronic-psychotic-disorders-in-tanzania-capacity-122729https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-treatment-for-schizophrenia-patients-with-auditory-hallucinations-122730https://curecurrent.com/trials/pentoxifylline-add-on-therapy-for-schizophrenia-122731https://curecurrent.com/trials/raloxifene-augmentation-in-patients-with-a-schizophrenia-spectrum-disorder-122732https://curecurrent.com/trials/study-of-the-effects-of-pantoprazole-on-levels-of-prescribed-psychiatric-medications-122733https://curecurrent.com/trials/study-of-the-effect-of-dosing-on-clozapine-levels-122734https://curecurrent.com/trials/a-study-of-alks-3831-in-subjects-with-schizophrenia-and-alcohol-use-disorder-122735https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-schizophrenia-122736https://curecurrent.com/trials/the-effect-of-the-psychoeducation-program-on-the-subjective-well-being-of-caregivers-122737https://curecurrent.com/trials/integrated-care-including-assertive-community-treatment-in-early-psychosis-122738https://curecurrent.com/trials/effects-of-oxytocin-on-negative-symptoms-and-social-cognition-in-schizophrenia-and-its-possible-mechanisms-122739https://curecurrent.com/trials/adapting-critical-time-intervention-to-support-inpatient-medical-care-transition-122740https://curecurrent.com/trials/a-study-of-a-remediation-program-of-social-cognition-in-schizophrenia-122741https://curecurrent.com/trials/modulation-of-repetitive-transcranial-magnetic-stimulation-on-hippocampal-neurogenesis-and-functional-network-in-patient-122742https://curecurrent.com/trials/the-effect-of-repetitive-transcranial-magnetic-stimulation-in-schizophrenia-122743https://curecurrent.com/trials/implementation-of-digital-cbt-for-insomnia-in-first-episode-psychosis-122744https://curecurrent.com/trials/involuntary-memories-investigation-in-schizophrenia-122745https://curecurrent.com/trials/assessment-of-efficacy-of-a-psychological-therapy-in-inpatients-with-a-schizophrenic-psychosis-122746https://curecurrent.com/trials/a-study-in-schizophrenic-patients-122747https://curecurrent.com/trials/an-observational-study-on-atypical-antipsychotics-long-term-treatment-patients-with-schizophrenia-122748https://curecurrent.com/trials/deep-transcranial-magnetic-stimulation-for-the-treatment-of-treatment-resistance-schizophrenia-122749https://curecurrent.com/trials/sustained-attention-abilities-in-schizophrenia-122750https://curecurrent.com/trials/early-identification-and-predictive-parsing-for-high-risk-group-of-schizophrenia-122751https://curecurrent.com/trials/an-adaptive-phase-ii-iii-two-part-double-blind-randomized-placebo-controlled-dose-finding-multi-center-study-of-the-safe-122752https://curecurrent.com/trials/correlation-between-cognitive-function-and-relapse-of-schizophrenia-regarding-dose-reduction-122753https://curecurrent.com/trials/development-of-a-mobile-heath-augmented-brief-suicide-prevention-intervention-for-people-with-smi-122754https://curecurrent.com/trials/a-trial-in-adult-participants-with-schizophrenia-treated-prospectively-for-6-months-with-abilify-mycite-122755https://curecurrent.com/trials/group-training-for-social-skills-in-psychosis-122756https://curecurrent.com/trials/neurobiological-effects-of-oxytocin-in-schizophrenia-122757https://curecurrent.com/trials/self-management-training-and-automated-telehealth-to-improve-smi-health-outcomes-122758https://curecurrent.com/trials/high-definition-transcranial-direct-current-stimulation-as-a-treatment-of-negative-symptoms-of-schizophrenia-122759https://curecurrent.com/trials/study-evaluating-the-effects-of-multiple-doses-of-nsa-789-in-subjects-with-schizophrenia-or-schizoaffective-disorder-122760https://curecurrent.com/trials/study-evaluating-the-effects-of-single-oral-doses-of-nsa-789-on-auditory-p50-suppression-in-schizophrenic-patients-122761https://curecurrent.com/trials/study-of-ly2140023-in-schizophrenia-comparing-ly2140023-olanzapine-and-placebo-122762https://curecurrent.com/trials/efficacy-and-mechanisms-of-low-intensity-focused-ultrasound-on-negative-symptoms-in-patients-with-schizophrenia-122763https://curecurrent.com/trials/a-study-of-dose-response-relationship-and-the-evidence-based-multisensory-stimulation-intervention-122764https://curecurrent.com/trials/the-gut-metagenome-research-of-schizophrenia-122765https://curecurrent.com/trials/evaluation-of-a-psychoeducation-program-for-families-caregivers-of-schizophrenic-patients-randomized-study-in-two-arms-122766https://curecurrent.com/trials/pharmacologically-augmented-cognitive-therapies-pacts-for-schizophrenia-122767https://curecurrent.com/trials/schizophrenia-and-ptsd-project-health-interventions-and-risk-resilience-evaluation-sapphire-study-122768https://curecurrent.com/trials/addition-of-ondansetron-to-ongoing-antipsychotic-treatment-for-schizophrenia-122769https://curecurrent.com/trials/brain-effects-of-memory-training-in-early-psychosis-122770https://curecurrent.com/trials/optimizing-and-individualizing-the-pharmacological-treatment-of-first-episode-schizophrenic-patients-122771https://curecurrent.com/trials/dynamics-of-risk-perception-and-risk-behavior-in-alcohol-use-disorder-and-schizophrenia-122772https://curecurrent.com/trials/the-effect-of-psycho-education-on-clinical-outcomes-among-patients-with-a-first-episode-psychosis-in-central-uganda-122773https://curecurrent.com/trials/motivation-and-skills-support-mass-122774https://curecurrent.com/trials/insight-enhancement-program-vs-metacognitive-training-for-psychosis-in-patients-with-schizophrenia-a-three-armed-compara-122775https://curecurrent.com/trials/pharmacologic-modulation-of-hippocampal-activity-in-psychosis-122776https://curecurrent.com/trials/cognitive-behaviour-therapy-for-voices-and-dissociation-122777https://curecurrent.com/trials/the-effects-of-different-modalities-of-exercise-in-patients-with-schizophrenia-122778https://curecurrent.com/trials/an-open-label-trial-of-tocilizumab-in-schizophrenia-122779https://curecurrent.com/trials/prediction-of-relapse-in-schizophrenia-schizoaffective-disorder-with-smartphones-and-on-body-sensors-122780https://curecurrent.com/trials/sulforaphane-to-reduce-symptoms-of-schizophrenia-122781https://curecurrent.com/trials/treatment-response-in-schizophrenia-bridging-imaging-and-postmortem-studies-122782https://curecurrent.com/trials/a-prospective-open-ended-multi-center-study-of-schizophrenia-patients-switching-to-zolodine-122783https://curecurrent.com/trials/a-phase-3-long-term-safety-and-tolerability-study-of-alks-3831-in-adults-with-schizophrenia-122784https://curecurrent.com/trials/cognitive-remediation-for-schizophrenia-122785https://curecurrent.com/trials/improving-visual-attention-in-schizophrenia-122786https://curecurrent.com/trials/improving-negative-symptoms-community-engagement-in-veterans-with-schizophrenia-122787https://curecurrent.com/trials/cannabis-and-schizophrenia-self-medication-and-agonist-treatment-122788https://curecurrent.com/trials/remediation-of-auditory-recognition-in-schizophrenia-with-tdcs-122789https://curecurrent.com/trials/nonverbal-synchrony-therapeutic-alliance-and-treatment-engagement-in-first-episode-schizophrenia-122790https://curecurrent.com/trials/a-study-to-evaluate-abt-126-for-the-treatment-of-cognitive-deficits-in-schizophrenia-122791https://curecurrent.com/trials/a-phase-2-study-to-evaluate-abt-126-for-the-treatment-of-cognitive-deficits-in-schizophrenia-122792https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-efficacy-of-180-mg-subcutaneous-risperidone-from-6-mg-oral-risperidone-122793https://curecurrent.com/trials/a-multiple-ascending-dose-trial-of-cvl-231-in-subjects-with-schizophrenia-122794https://curecurrent.com/trials/trial-of-stimulus-response-potentiation-in-schizophrenia-122795https://curecurrent.com/trials/improving-access-to-early-psychosis-coordinated-specialty-care-122796https://curecurrent.com/trials/study-of-m-resist-an-m-health-program-for-treatment-resistant-schizophrenia-122797https://curecurrent.com/trials/the-effects-of-three-different-modalities-of-exercise-in-patients-with-schizophrenia-122798https://curecurrent.com/trials/sleep-disturbances-in-patients-with-psychotic-symptoms-akusleep-122799https://curecurrent.com/trials/motivational-interviewing-in-patients-with-schizophrenia-122800https://curecurrent.com/trials/reducing-duration-of-untreated-psychosis-through-rapid-identification-and-engagement-122801https://curecurrent.com/trials/cbd-cigarettes-instead-of-normal-cigarettes-as-innovative-treatment-for-schizophrenia-122802https://curecurrent.com/trials/long-term-safety-of-spd489-when-added-to-stable-doses-of-antipsychotic-medications-in-clinically-stable-adults-with-nega-122803https://curecurrent.com/trials/spd489-low-dose-and-high-dose-ranges-when-added-to-stable-doses-of-antipsychotic-medications-in-clinically-stable-adults-122804https://curecurrent.com/trials/adjunctive-spd489-to-antipsychotic-medication-in-clinically-stable-adults-with-persistent-predominant-negative-symptoms-122805https://curecurrent.com/trials/comparison-of-maintenance-ect-versus-clozapine-in-treatment-resistant-schizophrenia-122806https://curecurrent.com/trials/a-tak-831-1001-single-and-multiple-rising-dose-study-in-healthy-participants-122807https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-spd489-in-adults-with-schizophrenia-and-predominant-negative-symptoms-122808https://curecurrent.com/trials/exploring-the-effectiveness-of-group-cognitive-stimulation-therapy-in-people-with-schizophrenia-122809https://curecurrent.com/trials/assess-the-safety-and-pharmacokinetics-of-ascending-multiple-oral-doses-of-spd489-in-adults-with-schizophrenia-122810https://curecurrent.com/trials/spd489-as-adjunctive-treatment-in-adults-with-negative-symptoms-of-schizophrenia-122811https://curecurrent.com/trials/effectiveness-of-trauma-therapy-in-patients-with-ptsd-and-comorbid-psychotic-disorder-122812https://curecurrent.com/trials/cognitive-remediation-program-for-hospitalized-in-the-long-term-patients-with-deficit-schizophrenia-122813https://curecurrent.com/trials/adjunctive-use-of-fute-flupentixol-in-multi-acting-receptor-targeted-antipsychotics-treated-schizophrenia-patients-122814https://curecurrent.com/trials/study-to-determine-the-safety-tolerability-and-efficacy-of-evenamide-in-patients-with-chronic-schizophrenia-122815https://curecurrent.com/trials/improving-negative-symptoms-of-psychosis-in-real-world-environments-122816https://curecurrent.com/trials/boost-rtms-for-auditory-verbal-hallucinations-122817https://curecurrent.com/trials/rct-of-tdcs-combined-with-cognitive-training-in-schizophrenia-122818https://curecurrent.com/trials/familial-schizophrenia-and-spectrum-personality-disorders-122819https://curecurrent.com/trials/bipolar-and-schizophrenia-consortium-for-parsing-intermediate-phenotypes-122820https://curecurrent.com/trials/brain-circuits-in-schizophrenia-and-smoking-122821https://curecurrent.com/trials/bio-equivalence-study-between-saphris-and-asenapine-122822https://curecurrent.com/trials/pan-european-collaboration-on-antipsychotic-na-ve-schizophrenia-ii-122823https://curecurrent.com/trials/biological-evaluation-of-dietary-supplement-liposomal-glutathione-122824https://curecurrent.com/trials/efficacy-and-mechanisms-of-transcranial-direct-current-stimulation-tdcs-effects-on-working-memory-in-schizophrenia-122825https://curecurrent.com/trials/early-detection-and-intervention-for-women-at-risk-of-psychosis-122826https://curecurrent.com/trials/effects-of-cannabidiol-on-psychiatric-symptoms-cognition-and-cannabis-consumption-in-cannabis-users-with-recent-onset-ps-122827https://curecurrent.com/trials/effect-of-intermittent-theta-burst-stimulation-itbs-for-alleviating-symptoms-of-schizophrenia-patients-122828https://curecurrent.com/trials/body-mind-spirit-intervention-for-women-with-early-psychosis-122829https://curecurrent.com/trials/peer-support-experience-for-patients-discharged-from-acute-psychiatric-care-122830https://curecurrent.com/trials/treating-refractory-schizophrenia-with-rtms-122831https://curecurrent.com/trials/a-single-ascending-dose-study-of-cy150112-after-single-oral-administration-in-healthy-chinese-subjects-122832https://curecurrent.com/trials/assessing-a-wechat-based-integrative-family-intervention-wifi-for-schizophrenia-122833https://curecurrent.com/trials/motivational-negative-symptoms-in-schizophrenia-intervention-and-biomarkers-122834https://curecurrent.com/trials/the-effect-of-psychoeducation-based-on-uncertainty-in-illness-theory-on-schizophrenia-caregivers-122835https://curecurrent.com/trials/the-appeal-and-impact-of-e-cigarettes-in-smokers-with-smi-122836https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-study-of-mk-8189-in-participants-with-schizophrenia-and-in-healthy-participan-122837https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-switching-from-quetiapine-to-ziprasidone-122838https://curecurrent.com/trials/safety-and-efficacy-of-ziprasidone-in-adolescents-with-schizophrenia-122839https://curecurrent.com/trials/extension-study-of-patients-successfully-treated-by-ziprasidone-in-study-a1281031-122840https://curecurrent.com/trials/side-effects-of-antipsychotic-medications-122841https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-two-period-cross-over-proof-of-activity-study-to-evaluate-the-effects-of-ta-122842https://curecurrent.com/trials/phase-1-tak-041-first-in-human-safety-tolerability-and-pharmacokinetics-study-122843https://curecurrent.com/trials/motive-specific-intervention-for-negative-symptoms-in-schizophrenia-122844https://curecurrent.com/trials/treatment-of-schizophrenic-patients-with-ziprasidone-122845https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-for-auditory-hallucinations-in-early-onset-schizophrenia-eos-122846https://curecurrent.com/trials/extension-study-evaluating-the-safety-of-oral-ziprasidone-in-the-treatment-of-subjects-with-schizophrenia-122847https://curecurrent.com/trials/safety-and-tolerability-of-ziprasidone-in-adolescents-with-schizophrenia-122848https://curecurrent.com/trials/one-year-trial-of-oral-ziprasidone-in-patients-with-metabolic-syndrome-122849https://curecurrent.com/trials/a-randomized-open-label-multi-center-study-to-evaluate-the-efficacy-and-safety-of-intramuscular-ziprasidone-in-patients-122850https://curecurrent.com/trials/targeting-stress-reactivity-in-schizophrenia-integrated-coping-awareness-therapy-122851https://curecurrent.com/trials/a-non-interventional-post-marketing-surveillance-study-to-evaluate-the-safety-and-efficacy-of-zeldox-capsule-122852https://curecurrent.com/trials/5-htr2a-drd2-and-comt-genes-polymorphisms-and-olanzapine-plasma-concentration-in-treatment-of-early-onset-schizophrenia-122853https://curecurrent.com/trials/lurasidone-effects-on-tissue-glutamate-in-schizophrenia-122854https://curecurrent.com/trials/brain-imaging-cognitive-enhancement-and-early-schizophrenia-122855https://curecurrent.com/trials/napls-omega-3-fatty-acid-versus-placebo-study-122856https://curecurrent.com/trials/clinical-trial-of-bi-425809-effect-on-cognition-and-functional-capacity-in-schizophrenia-122857https://curecurrent.com/trials/cultivating-well-being-in-severe-psychiatric-conditions-122858https://curecurrent.com/trials/event-related-potential-erp-biomarkers-in-subjects-with-schizophrenia-and-healthy-volunteer-subjects-122859https://curecurrent.com/trials/the-outcomes-among-persons-with-schizophrenia-under-the-peer-support-service-in-vocational-rehabilitation-program-122860https://curecurrent.com/trials/clinical-effect-of-cross-titration-of-antipsychotics-with-ziprasidone-in-schizophrenia-or-schizoaffective-disorder-122861https://curecurrent.com/trials/effect-and-safety-of-ziprasidone-compared-to-other-atypical-antipsychotic-drug-in-schizophrenic-patients-122862https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-intramuscular-ziprasidone-followed-by-oral-ziprasidone-for-the-treatment-of-psycho-122863https://curecurrent.com/trials/a-study-of-the-effects-of-ziprasidone-for-the-treatment-of-schizophrenia-or-schizoaffective-disorder-in-patients-who-wer-122864https://curecurrent.com/trials/kahn-study-investigation-of-the-efficacy-of-ziprasidone-versus-olanzapine-in-the-management-of-recent-onset-psychosis-a-122865https://curecurrent.com/trials/12-week-open-non-comparative-switch-study-of-oral-ziprazidone-in-previously-treated-schizophrenic-patients-122866https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-ziprasidone-and-aripiprazole-for-the-treatment-fo-schizophrenia-or-schizoaf-122867https://curecurrent.com/trials/ziprasidone-pharmacokinetics-using-a-reduced-food-effect-formulation-compared-to-pharmacokinetics-from-commercial-capsul-122868https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-ziprasidone-and-risperidone-for-the-treatment-of-schizophrenia-in-chinese-122869https://curecurrent.com/trials/a-study-comparing-the-safety-and-efficacy-of-ziprasidone-and-risperidone-for-the-treatment-of-chronic-schizophrenia-122870https://curecurrent.com/trials/ziprasidone-versus-olanzapine-in-the-treatment-of-schizophrenia-122871https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ziprasidone-in-patients-with-acute-exacerbation-of-schizophrenia-or-schizoaffectiv-122872https://curecurrent.com/trials/im-and-oral-in-acute-exacerbation-of-schizophrenia-bizet-study-122873https://curecurrent.com/trials/a-study-of-the-safety-and-tolerability-of-oral-ziprasidone-in-children-and-teens-with-psychotic-disorders-122874https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ziprasidone-for-the-treatment-of-acute-exacerbation-of-schizophrenia-or-schizoaffe-122875https://curecurrent.com/trials/mozart-relapse-study-122876https://curecurrent.com/trials/non-interventional-study-of-ziprasidone-in-the-treatment-of-bipolar-and-schizoaffective-disorders-122877https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-tolerability-of-ziprasidone-vs-clozapine-for-the-treatment-of-schizophrenia-in-patien-122878https://curecurrent.com/trials/cognitive-behavioral-social-skills-training-for-patients-with-late-life-schizophrenia-a-pilot-study-122879https://curecurrent.com/trials/is-cognitive-training-neuroprotective-in-early-psychosis-122880https://curecurrent.com/trials/differences-in-schizophrenia-with-one-month-and-3-month-paliperidone-palmitate-treatment-122881https://curecurrent.com/trials/decision-making-and-decision-support-among-emerging-adults-with-first-episode-psychosis-122882https://curecurrent.com/trials/goal-management-training-for-patients-with-schizophrenia-or-high-risk-for-schizophrenia-122883https://curecurrent.com/trials/multi-site-communication-deficits-in-schizophrenia-122884https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-basmisanil-in-participants-with-cognitive-impairment-associated-with-schizophrenia-ci-122885https://curecurrent.com/trials/molecular-variants-associated-with-schizophrenia-differential-analysis-of-monozygotic-twins-with-variable-phenotypic-22q-122886https://curecurrent.com/trials/compensatory-cognitive-training-in-clinical-high-risk-latino-youth-122887https://curecurrent.com/trials/connectomics-in-psychiatric-classification-of-bipolar-disorder-and-schizophrenia-122888https://curecurrent.com/trials/expanding-rapid-ascertainment-networks-of-schizophrenia-families-in-taiwan-122889https://curecurrent.com/trials/salutogenic-approach-based-interview-with-people-with-schizophrenia-122890https://curecurrent.com/trials/pharmacologic-treatment-of-acute-episode-of-schizophrenia-a-real-world-study-122891https://curecurrent.com/trials/effectiveness-of-aripiprazole-long-acting-injection-in-recent-onset-and-chronic-schizophrenia-patients-122892https://curecurrent.com/trials/a-multicenter-open-label-study-investigating-the-pharmacokinetics-and-safety-of-aripiprazole-im-depot-formulation-opc-14-122893https://curecurrent.com/trials/berberine-as-adjuvant-treatment-for-schizophrenia-patients-122894https://curecurrent.com/trials/patient-controlled-admissions-in-inpatient-mental-health-services-122895https://curecurrent.com/trials/biomarkers-in-first-episode-schizophrenia-122896https://curecurrent.com/trials/safety-blood-levels-and-effects-of-aut00201-122897https://curecurrent.com/trials/effectiveness-of-using-calligraphic-activity-to-people-with-schizophrenia-122898https://curecurrent.com/trials/decision-making-capacity-intervention-development-evaluation-in-schizophrenia-spectrum-disorder-122899https://curecurrent.com/trials/effect-of-hot-footbath-on-the-sleep-quality-122900https://curecurrent.com/trials/enhancement-of-treatment-of-delusions-in-schizophrenia-through-neuromodulation-122901https://curecurrent.com/trials/study-of-efficacy-of-pear-004-in-schizophrenia-122902https://curecurrent.com/trials/aripiprazole-im-depot-for-chinese-patients-with-schizophrenia-122903https://curecurrent.com/trials/aripiprazole-im-depot-in-the-acute-treatment-of-adults-with-schizophrenia-122904https://curecurrent.com/trials/pharmacodynamic-pharmacokinetic-study-of-aqw051-in-schizophrenia-122905https://curecurrent.com/trials/effect-of-aqw051-on-cognitive-function-in-patients-with-chronic-stable-schizophrenia-122906https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-once-daily-doses-of-aqw051-on-cognition-in-stable-schizophrenia-patients-122907https://curecurrent.com/trials/efficacy-and-safety-of-pimavanserin-as-adjunctive-treatment-for-the-negative-symptoms-of-schizophrenia-advance-122908https://curecurrent.com/trials/efficacy-study-of-galantamine-for-cognitive-impairments-in-schizophrenia-122909https://curecurrent.com/trials/searching-for-early-biomarkers-of-long-term-hepatic-metabolic-and-endothelial-dysfunction-in-non-affective-psychosis-122910https://curecurrent.com/trials/longitudinal-long-term-study-10-years-of-the-sample-of-first-episode-of-non-affective-psychosis-pafip-122911https://curecurrent.com/trials/quetiapine-and-the-dopaminergic-epigenetic-control-122912https://curecurrent.com/trials/personalizing-interventions-using-real-world-interactions-122913https://curecurrent.com/trials/safety-and-tolerability-of-single-and-multiple-doses-of-lb-102-in-healthy-adults-122914https://curecurrent.com/trials/comparison-of-a-long-acting-injectable-antipsychotic-vs-clinician-s-choice-early-in-treatment-to-break-the-cycle-of-rela-122915https://curecurrent.com/trials/prefrontal-cortical-engagement-through-non-invasive-brain-stimulation-in-schizophrenia-122916https://curecurrent.com/trials/antipsychotic-induced-structural-and-functional-brain-changes-122917https://curecurrent.com/trials/brain-imaging-in-early-psychosis-122918https://curecurrent.com/trials/effects-of-online-and-recovery-oriented-peer-support-groups-facilitated-by-peer-support-workers-in-times-of-covid-19-122919https://curecurrent.com/trials/pharmacogenomic-decision-support-with-genesight-psychotropic-to-guide-the-treatment-with-antipsychotics-122920https://curecurrent.com/trials/level-of-immersion-of-virtual-reality-and-cognition-and-motor-performance-in-patients-of-schizophrenia-spectrum-disorder-122921https://curecurrent.com/trials/cognitive-factors-mediating-the-relationship-between-childhood-trauma-and-auditory-hallucinations-in-schizophrenia-122922https://curecurrent.com/trials/stage-specific-case-management-for-early-psychosis-122923https://curecurrent.com/trials/evaluate-the-pk-of-ly03010-process-1-and-process-2-drug-product-vs-invega-sustenna-after-intramuscular-injection-in-schi-122924https://curecurrent.com/trials/linagliptin-and-mesenchymal-stem-cells-a-pilot-study-122925https://curecurrent.com/trials/good-shepherd-back-to-reality-series-122926https://curecurrent.com/trials/the-application-of-wearable-technology-to-improve-the-physical-activity-level-of-people-with-chronic-mental-illness-122927https://curecurrent.com/trials/phase-iv-to-evaluate-the-safety-of-self-administered-adasuve-in-agitated-patients-outside-the-hospital-setting-122928https://curecurrent.com/trials/bilateral-repetitive-transcranial-magnetic-stimulation-for-auditory-hallucinations-results-122929https://curecurrent.com/trials/a-study-to-assess-safety-and-efficacy-of-karxt-in-adult-patients-with-schizophrenia-122930https://curecurrent.com/trials/the-use-of-transcranial-electrical-stimulation-for-hallucinations-122931https://curecurrent.com/trials/flexible-dose-long-term-safety-study-of-lu-af35700-in-adult-patients-with-schizophrenia-122932https://curecurrent.com/trials/validation-of-a-tool-for-the-dimensional-assessment-of-apathy-in-a-population-suffering-from-schizophrenia-122933https://curecurrent.com/trials/early-diagnosis-of-intracranial-infection-after-craniotomy-122934https://curecurrent.com/trials/study-to-assess-efficacy-and-safety-of-hp3070-in-subjects-diagnosed-with-schizophrenia-122935https://curecurrent.com/trials/comparison-of-e-health-vs-in-person-multi-family-group-mfg-122936https://curecurrent.com/trials/simvastatin-addition-for-patients-with-recent-onset-schizophrenia-122937https://curecurrent.com/trials/nicotine-and-sensorimotor-replacement-for-smoking-in-smokers-with-schizophrenia-122938https://curecurrent.com/trials/double-blind-placebo-controlled-randomised-investigation-of-ondansetron-in-schizophrenia-122939https://curecurrent.com/trials/psychological-therapy-for-dissociation-trauma-and-voices-a-single-case-experimental-design-122940https://curecurrent.com/trials/convergent-and-concurrent-validity-between-clinical-recovery-and-personal-civic-recovery-in-mental-health-122941https://curecurrent.com/trials/d-serine-and-cognitive-remediation-in-schizophrenia-122942https://curecurrent.com/trials/brain-activation-patterns-in-schizophrenia-after-computerized-cognitive-skills-training-122943https://curecurrent.com/trials/safety-and-effectiveness-of-d-serine-in-schizophrenia-122944https://curecurrent.com/trials/cognitive-remediation-therapy-for-participants-with-late-life-schizophrenia-122945https://curecurrent.com/trials/diagnostic-announcement-to-relatives-of-patients-with-schizophrenia-122946https://curecurrent.com/trials/nurse-led-psycho-education-program-for-people-with-first-onset-mental-illness-apn-pep-122947https://curecurrent.com/trials/treating-cognition-in-schizophrenia-with-atomoxetine-and-cognitive-remediation-122948https://curecurrent.com/trials/mindfulness-group-based-intervention-for-early-psychosis-122949https://curecurrent.com/trials/a-long-term-study-of-clozapine-in-patients-with-treatment-resistant-schizophrenia-122950https://curecurrent.com/trials/study-with-lu-af11167-for-the-treatment-of-negative-symptoms-in-patients-with-schizophrenia-122951https://curecurrent.com/trials/flexible-dose-long-term-extension-study-of-lu-af11167-in-patients-with-schizophrenia-with-prominent-negative-symptoms-122952https://curecurrent.com/trials/theta-tacs-during-working-memory-training-a-pilot-study-of-the-effects-on-negative-symptoms-of-schizophrenia-122953https://curecurrent.com/trials/targeting-physical-health-in-schizophrenia-physical-activity-can-enhance-life-122954https://curecurrent.com/trials/bilateral-repetitive-transcranial-magnetic-stimulation-for-auditory-hallucinations-original-study-122955https://curecurrent.com/trials/assessing-the-effect-of-compensatory-cognitive-intervention-among-people-with-severe-mental-illness-122956https://curecurrent.com/trials/effectiveness-of-a-cardiovascular-risk-intervention-program-in-patients-with-schizophrenia-prisca-122957https://curecurrent.com/trials/ect-in-ultra-resistant-schizophrenia-122958https://curecurrent.com/trials/problem-solving-based-bibliotherapy-program-for-family-caregivers-122959https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-glial-activation-in-psychotic-disease-states-122960https://curecurrent.com/trials/a-problem-solving-based-bibliotherapy-program-for-family-caregivers-in-schizophrenia-122961https://curecurrent.com/trials/exploring-the-effects-of-a-baduanjin-program-on-the-symptoms-of-constipation-in-patients-with-schizophrenia-spectrum-122962https://curecurrent.com/trials/effectiveness-of-a-nurse-facilitated-face-care-group-in-patients-with-schizophrenia-122963https://curecurrent.com/trials/phosphatidylcholine-supplementation-in-infants-122964https://curecurrent.com/trials/trial-to-assess-the-bioavailability-of-quetiapine-versus-seroquel-in-subjects-with-schizophrenia-or-bipolar-disorder-122965https://curecurrent.com/trials/a-trial-of-single-and-multiple-doses-of-aripiprazole-in-adult-subjects-with-schizophrenia-or-bipolar-i-disorder-122966https://curecurrent.com/trials/brain-stimulation-and-cognitive-training-122967https://curecurrent.com/trials/european-long-acting-antipsychotics-in-schizophrenia-trial-122968https://curecurrent.com/trials/study-on-the-gut-microbial-mechanism-of-negative-symptoms-of-schizophrenia-122969https://curecurrent.com/trials/study-on-examination-of-therapeutic-efficacy-and-potential-mechanisms-of-yoga-treatment-in-schizophrenia-122970https://curecurrent.com/trials/smart-design-to-compare-antipsychotic-treatments-in-treatment-resistant-schizophrenia-122971https://curecurrent.com/trials/atypical-antipsychotics-influence-on-the-safety-of-the-heart-and-monitoring-indicators-model-building-122972https://curecurrent.com/trials/cognitive-and-emotional-factors-in-visual-exploration-among-patients-with-schizophrenia-122973https://curecurrent.com/trials/prediction-of-violent-behavior-in-patients-with-schizophrenia-by-multimodal-machine-learning-122974https://curecurrent.com/trials/effects-of-narrative-enhancement-and-cognitive-therapy-nect-on-self-stigma-in-patients-with-schizophrenia-122975https://curecurrent.com/trials/research-on-accurate-prediction-of-long-term-medication-use-for-schizophrenia-based-on-cognitive-function-122976https://curecurrent.com/trials/comparing-cognitive-remediation-approaches-for-schizophrenia-122977https://curecurrent.com/trials/the-effectiveness-of-assertive-community-treatment-on-schizophrenic-patients-122978https://curecurrent.com/trials/a-study-of-aripiprazole-lauroxil-or-paliperidone-palmitate-for-the-treatment-of-schizophrenia-122979https://curecurrent.com/trials/rtms-on-mismatch-negativity-of-schizophrenia-122980https://curecurrent.com/trials/substance-misuse-to-psychosis-for-ketamine-stop-k-122981https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-aut00206-in-patients-with-schizophrenia-and-also-explores-the-effects-of-aut-122982https://curecurrent.com/trials/best-event-schizophrenia-trial-a-randomized-double-blind-trial-of-aripiprazole-and-risperidone-in-schizophrenia-122983https://curecurrent.com/trials/thinking-skills-at-work-cognitive-remediation-therapy-for-patients-with-serious-mental-illness-122984https://curecurrent.com/trials/occupational-recovery-after-first-episode-psychosis-122985https://curecurrent.com/trials/implementation-and-evaluation-of-a-family-based-intervention-program-for-children-of-mentally-ill-parents-122986https://curecurrent.com/trials/animal-assisted-therapy-in-patients-with-schizophrenia-122987https://curecurrent.com/trials/avatar-therapy-in-comparison-to-cognitive-behavioral-therapy-for-treatment-resistant-schizophrenia-122988https://curecurrent.com/trials/a-trial-to-explore-acceptance-and-performance-of-using-a-digital-medicine-system-with-healthcare-professionals-and-adult-122989https://curecurrent.com/trials/technology-enabled-collaborative-care-for-youth-122990https://curecurrent.com/trials/pk-study-of-aripiprazole-im-depot-for-chinese-patients-with-schizophrenia-122991https://curecurrent.com/trials/a-study-in-italy-about-evidence-based-psychosocial-rehabilitative-interventions-in-patients-with-early-schizophrenia-tre-122992https://curecurrent.com/trials/electroencephalogram-eeg-and-electroconvulsive-therapy-ect-response-in-schizophrenia-122993https://curecurrent.com/trials/effect-of-vortioxetine-on-cognitive-symptoms-in-patients-with-schizophrenia-122994https://curecurrent.com/trials/critical-time-intervention-task-shifting-randomized-controlled-trial-122995https://curecurrent.com/trials/magnetic-seizure-therapy-mst-for-treatment-resistant-depression-schizophrenia-and-obsessive-compulsive-disorder-122996https://curecurrent.com/trials/bergen-psychosis-project-2-the-best-intro-study-122997https://curecurrent.com/trials/representations-and-strategies-for-recovery-122998https://curecurrent.com/trials/efficacy-and-safety-of-adjunctive-pimavanserin-for-the-treatment-of-schizophrenia-enhance-1-122999https://curecurrent.com/trials/effectiveness-of-the-individualized-metacognitive-training-emc-in-people-with-psychosis-of-brief-evolution-123000https://curecurrent.com/trials/lifestyle-redesign-for-schizophrenia-123001https://curecurrent.com/trials/hormonal-and-inflammatory-biomarkers-and-response-to-cognitive-remediation-in-recent-onset-psychosis-123002https://curecurrent.com/trials/feasibility-and-outcomes-of-a-digital-health-support-for-the-schizophrenia-spectrum-123003https://curecurrent.com/trials/effects-of-12-weeks-walking-on-cognitive-function-in-schizophrenia-123004https://curecurrent.com/trials/pet-imaging-study-of-amish-and-mennonite-patients-with-cntnap2-mutations-123005https://curecurrent.com/trials/impact-of-stigma-in-siblings-of-young-patients-with-schizophrenic-disorders-123006